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ABSTRACT OF THESIS 
INFLUENCE OF DIETARY SELENIUM SUPPLEMENTATION FORM ON 
HEPATIC TRANSCRIPTOME PROFILES OF MATURING BEEF HEIFERS 
 
Our objective was to know how the hepatic transcriptome expression of 
growing beef (Angus-cross) heifers (0.5 kg gain/day) was affected by the feeding of 
different sources of dietary (3 mg/day) Se supplements: inorganic Se (ISe, sodium 
selenite), organic (OSe, Sel-Plex®), or a blend (1.5 mg:1.5 mg) of ISe:OSe (Mix), 
compared to the adequate but non-Se supplemented “Control”. The biopsied hepatic 
tissues of these four groups heifers collected at day 168 (when liver Se assimilation 
had stabilized) after supplements of Se, was subjected to the microarray analysis to 
assess Se treatment effects.   
The results suggest that there were clear differences in the hepatic gene 
expression profile of the four Se treatment groups. 139 significantly treatment-
induced differentially expressed transcripts were selected. Among them: 1) the gene 
expression profiles of Control and OSe appeared to be more similar than Control and 
ISe, 2) eight distinct gene expression patterns among treatments were identified and 
each of them indicates affected biofunctions and networks, 3) they were grouped as 
the expression profile relative to Control, there were solely and commonly affected 
transcripts for four Se treatments and they indicated different biofunctions, 4) of them, 
three microRNAs were identified and their predicated mRNA targets showed different 
biofunctions.  
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Chapter 1: Introduction 
 
As the largest segment of the American agricultural economy, the cattle 
industry comprises approximately 1.23 million businesses with cattle, including beef 
and dairy cattle. An estimated 1.064 million farmers and ranchers raise beef cattle in 
the United States (Kentucky Beef Book, 1997). As one of the largest beef producing 
states east of the Mississippi river, Kentucky is home to over 1.16 million beef cows 
with a total cattle inventory of some 2.40 million head (Kentucky Beef Council, 2010). 
Cattle producers generate more than $605 million dollars in cash sale receipts in 2007 
(Kentucky Beef Council, 2010) According to recent data, beef cattle are produced on 
45,000 (50.6 percent) of Kentucky’s 89,000 farms (Kentucky Beef Book, 1997). 
Therefore, cattle production is very important to many farmers in Kentucky.  
Se is a metalloid belonging to Group VIA of the Periodic Table, the same as 
sulfur. Selenium plays an important role in regulation of various physiological 
functions in beef cattle including immunity, reproduction and early postanatal 
viability (Suzuki, 2005). Se deficiency alone, or in combination with vitamin E, is 
associated with reduced growth and productivity rates (Surai, 2006), early mortality 
(Surai, 2006) and immune-suppression (Surai, 2006). Se deficiency has been 
specifically linked with the development of various diseases in ruminants (Pehrson, 
1993; Kolb and Seehawer, 2001) including nutritional muscular dystrophy (white 
muscle disease, the most well documented disease related to Se/vitamin E deficiency 
in ruminants), retained placenta and metritis (affecting about 9% of USA dairy 
industry births), and mastitis (estimated annual cost is $17,500 for a 100-cow herd) 
(Surai, 2006).  
 The amount of Se available for the grazing beef cattle is dependent on Se 
content of the forages (McDowell, 1996). The concentration and availability of Se in 
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the soil determines the Se content of forages and the Se requirement for beef cattle 
among all ages is 0.10 mg Se/kg of diet (NRC, 2000). The Se content in forages (and 
grains) of the southeast USA (including Kentucky) is low (＜ 0.05 mg Se/kg) to 
variable (＜ 0.1 mg/kg) (Ammermann et al., 1975). Consistently, a survey of whole 
blood Se concentrations of beef cows and heifers from 253 cow-calf operations in 18 
states (Dargatz and Ross, 1996) found that 42% of southeastern USA (including 
Kentucky) cattle were Se deficient (≤0.080μg/mL), as opposed to 18% nationally. 
Therefore, dietary supplementation of Se is necessary in Kentucky.  
Se supplementation is regulated by the Food and Drug Administration and 
cannot exceed 120 mg Se/kg or an intake of 3 mg per day when delivered in free-
choice mineral supplements to cattle (FDA, 1987). Se can be added to diets in either 
inorganic or organic forms. Historically, the supplemental inorganic forms of Se 
typically used are sodium selenite or sodium selenate (Brennan et al., 2011), despite 
the knowledge that Se primarily is present in plants as organic forms. Organic forms 
of Se include selenomethionine (SeMet) and selenocysteine (SeCys), which are 
typically added to ruminant diets as constituents of Se-enrich yeast extracts (e.g., 
SeMet is the predominant form of Se in Sel-Plex
®
 (Alltech Biotechnologies, Inc., 
Nicholasville, KY) (Korhola et al., 1986).  
Even though they have different delivery speeds to liver (Kazuo and Suzuki, 
2005), few differences in glutathionine peroxidase (GSH-Px) activities and Se 
concentrations in blood and milk result from feeding selenite versus selenate to 
heifers (Ortman et al., 1999). However, it may be reasonable to expect few 
differences as selenate is probably converted to selenite in the rumen (Weiss, 2003). 
The effect of supplementing diets with inorganic (ISe) versus organic (OSe) 
forms of Se on Se bioavailability and bioactivity also has been compared. 
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Assimilation of Se after 105-106 days by whole blood, red blood cells, and biopsied 
liver tissue was greater for heifers fed 3 mg/day of Se as Sel-Plex
®
 versus sodium 
selenite (Liao et al., 2011). Similarly, Se concentrations (219 to 257 µg/kg wet weight) 
in the liver of cows supplemented with 3 mg/day as Se-yeast (Sel-Plex 50
®
) was 1.2-
1.5 fold higher than with sodium selenite (Ortman and Pehrson, 1997). Thus, the 
bioavailability (defined as blood and tissue Se concentrations) of Se from OSe sources 
is higher than the ISe sources.  
Regarding production responses to feeding OSe versus ISe, few studies have 
found major differences between average daily gain, average daily feed intake, or gain: 
feed ratios, or any other production performance parameter (Davis et al., 2008; Liao 
2011; Nicholson, et al., 1991; Gunter et al., 2003). However, feeding organic forms of 
Se to dams may have positive effects on their offspring. For example, feedlot steers 
(Clyburn et al., 2007) and calves born from OSe-supplemented cows (Guyot et al., 
2006) tend to have better average daily gain compared to calves from ISe 
supplemented cows.  As for the Se biopotency (GSH-Px activity), different 
experiments on beef cattle have demonstrated that supplementation of OSe (as Se 
yeast) will increase blood Se GSH-Px versus ISe (sodium selenite) for weaned beef 
steers (Fry et al., 2005; Gunter et al., 2003; Guyot, et al., 2007; Nicholson, et al., 
1991). This finding indicates that the Se biopotency is higher for beef cattle if dietary 
OSe is supplemented versus ISe. Similarly, with regard to the animal responses under 
stress condition including animal immunocompetence, OSe supplementation is 
reported to induce higher states of immunocompetence than ISe, including increased 
macrophage phagocytosis (Beck et al., 2005), higher production of antibodies in 
response to antigen after infection (Nicholson et al., 1993), and decreased mean milk 
somatic cell counts (Harrison et al., 2005). Such positive results in biopotency and 
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immunocompetency with OSe versus ISe fed cattle, have led some to recommend that 
OSe replace ISe forms of Se in cattle diets (Surai, 2006). 
Recently a formulation of mixed (1:1) inorganic-organic Se supplements has 
been used in beef cattle mineral mixes as the source of Se (University of Kentucky 
Beef Cattle Mineral Mix). However, how this “mix” affects tissue Se assimilation and 
metabolism relative to OSe or ISe Se sources is not known. To initiate such 
comparisons, the diet of beef heifers was supplemented with none (Control) or 3.0 mg 
Se/day as ISe, OSe (Sel-Plex
®
),or Mix (1.5 mg Se/day as ISe:1.5 mg Se/day as OSe) 
for 224 days (Brennan et al., 2011). More Se was found in whole blood, red blood 
cells, serum, and liver of Mix and OSe heifers than ISe heifers, and all Se 
supplementation treatments resulted in greater Se assimilation than for non-
supplemented Control heifers. As stated by the authors, from a biochemical 
perspective, the observed differences in steady-state Se assimilation by tissues 
resulting from consumption of OSe versus ISe likely reflects the known common and 
different metabolic fates of organic and inorganic Se forms and, by extension, may 
provide insight into why consumption of a mix of 1.5 mg OSe and 1.5 mg of ISE 
resulted in liver assimilation of Se that was equal to consumption of 3 mg/day of OSe 
and greater than ISe (Brennan et al., 2011).  
To better understand effects of different forms of Se supplementation of beef 
cattle diets on whole-animal parameters and Se-specific metabolism, knowlege about 
how the forms of supplemental Se may affect global gene expression profiles is 
critical. However, with the exception of a pilot study by this research group (Liao et 
al., 2010), no research has been conducted to determine the effect of dietary Se 
supplementation on gene expression by beef cattle. The Liao et al. (2010) experiment 
revealed that expression of about 80 genes by the liver of slow maturing beef heifers 
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was altered by daily supplementation (105-106 days) of diets with 3 mg Se/day of ISe 
or OSe versus non-suplemented, but Se adequate, cohorts. Because, however, only a 
single time point was used in the experiment, it was not known if these differences 
reflected stable or transient responses to forms of Se supplement.  
To address this issue, and to determine the effect of a “mixed” Se supplement 
consisting of 1:1 sodium selenite: Sel-Plex
®
 (Mix), an expanded experiment (Brennan 
et al., 2011) using the same animal model (maturing beef heifers and cottonseed hull-
based diet) was conducted over a 224-day period using 3 mg Se/day dietary 
supplement treatments (n=10) of ISe, Sel-Plex
®
, or Mix. Importantly, this study found 
that liver Se concentrations were plateaued and stable after 112 days of 
supplementation.   
Thesis objective 
Therefore, using day 168 liver tissue samples from this experiment (Brennan 
et al., 2011) and microarray methodologies, the first objective was to test the 
hypothesis that the hepatic transcriptome profiles identified in biopsied liver samples 
from maturing beef heifers would be affected by the form of supplemental Se 
consumed. The secondary objective was to conduct bioinformatic analyses of these 
profiles to predict ostensible changes in physiological capacities induced by feeding 
different forms of supplemental Se.  
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Chapter 2: Literature Review 
Se specification 
Selenium exists as inorganic and organic forms (Foster and Sumar, 1997). The 
Se ion is conserved in minerals and soils (Underwood and Suttle, 2000). Plants 
assimilate inorganic Se from soils and convert Se it into inorganic and organic forms 
(Finley, 2005). Thus, the amount of Se contained in forages dictates the Se status of 
grazing animals.   
As mentioned in the Introduction, the Se requirement for beef cattle is 0.10 mg 
Se/kg of diet (NRC, 2000). In Kentucky with its Se-deficient soils, the predominant 
forage is tall fescue and the average Se content of tall fescue is 0.06 mg/kg (John et al., 
2003). Thus, Kentucky cattle typically consume Se-inadequate forages.  
Plants can be divided into two groups with regard to Se. One is called “non-
Se-accumulating”, and the major Se species in this group are selenate and SeMet, plus 
smaller amounts of SeCys (Jacobs, 1989). The other group is known as “Se-
accumulating”, and the predominant form of Se is γ-glutamyl methylSeCys (Shrift 
and Virupaksha, 1965; Terry et al., 2000). From recent findings, the major forms of 
Se available in feedstuffs for animals are SeMet and SeCys (Huerta et al., 2004). 
SeMet is predominant in cereals (Fairweather-Tait et al., 2010). Many plants contain 
plentiful SeMet because they have proteins that are high in sulfur-containing amino 
acids, and SeMet can nonspecifically replace Met in binding to tRNAmet (Fairweather-
Tait et al., 2010). SeMet also is the main Se compound in yeast and has been 
identified after enzymatic digestion or acid hydrolysis (Gammelgaard et al., 2008). 
Plants take up huge amounts of Se from the soil and transform it through 
several biochemical steps into volatile species, a process called phytovolatilization 
(Dumont et al., 2006). DMSe (Dimethyl Selenide) is the main phytovolatilization 
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product (Dumont et al., 2006). SeMet is favored for volatilization process, however, 
SeCys is incorporated into proteins, hence, is no longer available for volatilization. 
Inorganic Se from soils can be incorporated into the SeCys by plants (Ellis and Salt, 
2003). After incorporation, the SeCys can be incorporated into Se-proteins. The 
SeCys can also be metabolized into various non-proteinogenic Se amino acids 
(Neuhierl et al., 1999). Their synthesis occurs along the S-pathway (Dumont et al., 
2006). Three metabolites: Se-MeSeCys, Se-Cystathionine and γ-glu-SeMeSeCys are 
converted from the SeCys. The formation of Se-Cystathionine results in its 
accumulation of it because the enzyme cystathionine β-lyase is unable to cleave this 
Se analogue (Terry et al., 2000).  
Se deficiency 
It has been reported that Se deficiency is associated with physiological 
discomfort and diseases in ruminant animals, including nutritional muscular 
dystrophy and white muscle disease (the most well documented disease related to 
Se/vitamin E deficiency in ruminants), retained placenta (retained fetal membranes) 
and metritis (affecting about 9% of all calvings in US dairy industry births), mastitis 
(costs $100-200/cow/year or about $17,500 annually for an average 100-cow herd), 
unthriftiness and reduced growth rate, reduced reproduction rates, 
immunosuppression and increased susceptibility to various disease, and sub-optimal 
productivity and early mortality (Surai, 2006; Pehrson, 1993; Kolb and Seehawer, 
2001). Thus, the maintenance of Se in an adequate level for the beef cattle is critical.   
Se requirements for cattle 
It is recommended that diets consumed by beef cattle at all stages of life 
(calves, heifers and lactating and dry cattle) should be 0.10 mg Se/kg of diet, and that 
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the maximal amount of supplemental Se not exceed 3.0 mg Se per day (NRC, 2000). 
The Se level in cattle has been classified as adequate, marginal and deficient when Se 
level in plasma/serum were >75, 50-75 and <50 ng/ml; in whole blood >200; 140-200 
and <140 ng/ml, in liver >1.25, 0.6-1.25 and < 0.5 ng/mg dry matter, respectively 
(Smith et al., 1998; Zarski et al., 1998; Kincaid, 1999). During some specific periods 
such as reproductive period, the requirement of Se is increased, thus the original Se 
sources cannot meet the Se requirement of cattle and additional Se supplement is 
necessary (Maus et al., 1980).  
Se availability for cattle  
The amount of Se available for grazing beef cattle is dependent on the forages 
(FDA, 2007). As the plant Se is originally from inorganic Se in the soil, the 
concentration and availability of Se in the soil determine the Se content of forages 
(Hintze et al., 2001). For the areas where soil Se is deficient, beef cattle are more 
easily subjected to Se deficiency. The geographic distribution of Se in forages and 
grains, the southeast USA (including Kentucky) have low (80% of all forage and 
grain contain < 0.05 mg Se/kg) to variable (50% of all forage and grain contain < 0.1 
mg/kg) Se (Juniper et al., 2008). Forty-two percent of cattle in the southeastern United 
States (including Kentucky) were Se deficient (≤ 0.080μg/mL) compared to 18% of 
deficient animals nationally after testing whole blood Se concentrations of cattle and 
heifers from 253 cattle-calf operations in 18 states (Dargatz and Ross, 1996). Thus, 
the supplementation of Se for beef cattle is important in geographical areas where Se 
is not adequately available for cattle, including Kentucky.  
9 
 
Se supplementation 
Mineral supplements for feedlot cattle are incorporated into their concentrate 
diets. However, cattle grazing Se-deficient feedstuffs can receive mineral supplements 
through a variety of delivery systems (Wichtel, 1998; Hemingway, 2003). These 
include licks, drenching with Se compounds, intraruminal boluses, selenite or selenate 
injections, depot injections, adding sodium selenite to the drinking water, various 
methods of pasture and soil application, and by adding Se into feedstuffs (McDowell, 
1996; Pavlata et al., 2001). Dietary Se supplements added in feedstuffs can be further 
divided into organic and inorganic according to their chemical forms. Inorganic Se 
supplements are frequently used and treated as an ordinary Se supplements for 
ruminant (Azzi et al., 2005). However, irrespective of methods of Se supplementation 
used, Se inadequacy in beef cattle is still a global problem. This is partly due to usage 
of inorganic forms of Se with low Se availability. Therefore, how to supply Se in 
more available is an ongoing area of research. Organic Se can substantially improve 
Se status of beef cattle and research is still ongoing to define out how to optimally 
relieve the Se deficiency by organic Se. For this reason, and to understand whether 
inorganic vs organic forms of dietary Se differentially affect cell function, it’s crucial 
to understand Se metabolism.  
Se Metabolism 
Selenium metabolism consists of absorption, transfer, incorporation into body 
proteins, and excretion of Se. In mammals, organic and inorganic Se forms follow 
different metabolic pathways, although there are overlapping components. This 
metabolism is affected by such factors as the chemical form of Se, level of Se in 
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blood and tissues before supplementation, presence of various minerals and amino 
acids in the diet, and concentration of Se in the diet (Thomson, 1998).  
Absorption 
The absorptive mechanisms for Se have not been fully characterized. Several 
factors can affect efficiency of Se absorption, including the form of the element, the 
amount that was ingested, and other dietary factors such as calcium, arsenic, cobalt 
and sulfur can affect Se absorption by 50% or more (Surai, 2006). In general however, 
most Se is efficiently absorbed in the small intestine (Schrauzer, 2000), just over half 
is retained, (ie, not excreted in the urine) (Bugel et al., 2003), and subsequent 
metabolism depends on the form in which Se is present in plasma (Fairweather-Tait et 
al., 2010). 
Balance trials with grower-finisher pigs evaluated sodium selenite vs Se-
enriched yeast at various dietary Se levels (0.1, 0.3, or .5 ppm Se). As dietary Se 
levels increased, urinary Se increased more when pigs were fed sodium selenite 
(Mahan and Parrett, 1996). Selenium retention (a percentage of Se intake) was greater 
(P = 0.01) when organic Se (0.3 ppm of Se from Sel-Plex) was supplemented 
compared with inorganic Se (sodium selenite) to broilers for 6-wk (Yoon et al,. 2007). 
Selenium retention in the liver, kidney, pancreas and loin of growing-finishing pigs 
was higher when pigs were fed organic Se (Se-enriched yeast) than the same amount 
of inorganic Se (selenite Se). (Tian et al., 2006)  
Different forms of dietary Se also are absorbed at different rates. It was 
reported that selenate has the most efficient absorption, nearly 100%, but a significant 
fraction is lost in the urine; 90% of SeMet is absorbed; SeCys is absorbed very well; 
＞50% of selenite is absorbed and is better retained than selenate (US Food and 
Nutrition Board, 2000). Even though selenate and selenite are more efficiently 
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absorbed, they are less retained vs the organic forms of Se, SeMet and SeCys 
(Ammerman and Miller, 1975; Thomson et al., 1978; Schrauzer, 2000; Burk et al., 
2006). Thus, considering only tissue retention as a criterion, feeding organic forms of 
Se may be the more efficient method of supplementing Se to animal diets.  
Blood Transfer 
After absorption, Se is transferred in blood bound to alpha- and gamma-
globulins and delivered to the liver to synthesize selenoproteins (Ceballos and 
Wittwer, 1996). It was reported that SeMet-Se is incorporated into a longer term body 
pool than the selenite-Se: It is steadily incorporated into erythrocytes during a period 
of 8-12 weeks and plasma Se reached a maximum 3-4 h after administration and 
about 4-8 h sooner than after the administration of an equivalent dose of selenite; 
selenite increased the blood until a plateau was reached after 7-8 weeks (Schrauzer, 
2003).  
Incorporation of Se into proteins 
Selenium can be incorporated into proteins to form Se-containing proteins and 
selenoproteins. The Se-containing proteins are proteins either with non-specific 
incorporation of Se (usually SeMet) or specific Se-binding proteins. In contrast, 
selenoproteins are specific proteins containing Se in the form of genetically encoded 
SeCys (Behne and Kyriakopoulos, 2001; Almondes et al., 2010). Different from 
proteins that bind zinc and copper to form coordinated to functional groups, SeCys 
and SeMet residues are constituent residues in polypeptides (Suzuki, 2005).  
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Selenium-specific Metabolic Pathways  
General metabolism 
The metabolism of organic and inorganic forms of Se have both common and 
different metabolic fates. Selenate, selenite, SeMet, and SeCys all enter the selenide 
pool and from here the Se is either converted to selenophosphate and used for 
synthesis by specific tRNAs or excreted in the urine as a selenosugar (Schrauzer, 
2003; Fairweather-Tait et al., 2010). Specifcally, SeCys and SeMet are thought to be 
the most common forms of dietary OSe. In the ruminant, absorbed SeCys (originating 
from dietary or microbial protein), will be transformed to selenide by cleavage of the 
C-Se bond at the beta position by beta-lyase, this step is involved the production of 
alanine (Ohta and Suzuki, 2008). Besides, the methyltransferases can transfer one-
carbon groups to SeCys to become methylSeCys, the later will be converted to gama-
glutamyl-Se-methyl-SeCys, methyl-seleno-pyruvate, or methylselenol that functions 
as an intermediate of Se excretion and selenoprotein synthesis. The selenide 
undergoes an ATP required reaction to synthesize the selenophosphate by 
selenophosphate synthetase. The transfer RNA for selenocysteine will be 
aminoacylated with serine to become tRNA
[Ser]
Sec, then binds with the 
selenophosphate to form phosphoseryl-tRNA
[Ser]
Sec by O-phosphoryl tRNA Sec 
kinase, and further converts to selenocysteyl-tRNA
[Ser]
Sec by the Selenocysteine 
synthase. Along with some transcription factors, the selenocysteryl-tRNA
[Ser]
Sec will 
bind to the UGA codon to synthesize the selenoproteins, however, SeMet can 
incorporate into polypeptide chains using the same mechanisms of Met to synthesize 
Se-containing proteins in whole body by the transfer RNA for Met, but it can also 
transfer to SeCys similar to how Met transfers to Cys to synthesize selenoproteins 
when the body is under a relative Se-deficiency environment. Also, SeMet can be 
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transformed to methylselenol through cleavage of the C-Se bond at the γ-position of 
SeMet and then the methylselenol is transformed to selenide.  
Inorganic Se (selenite and selenate) are reduced to selenide by thioredoxin 
reductases, and the resulting selenide used to synthesize selenoproteins. Selenate can 
convert to selenite but this step differs from mammal compared to bacteria. In 
mammals, the bifunctional enzyme phosphoadenosine-phosphosulfate synthase will 
catalyze two steps. Sulfate adenylyltransferase catalyzes the formation of adenosine 
5'-phosphosulfate (APS) from ATP and selenate, and APS is bound by 
adenylylsulfate kinase portion of 3'-phosphoadenosine 5'-phosphosulfate (PAPS) 
synthase to selenite (Bandurski et al., 1956; Hilz and Lipmann, 1955; Venkatachalam 
et al., 1998). In contrast, in bacteria, this reaction is carried out by selenate reductase 
(Schroder et al., 1997; Macy et al., 1993; Krafft et al., 2000; Stolz and Oremland, 
1999). At the same time, selenite can also be converted back to selenic acid, and the 
latter adenylylated to adenylylselenate and then phosphoralated to 
phosphoadenylylselenate. Both of these steps are catalyzed by bifunctional 
phosphoadenosine-phosphosulfate synthase (Lehninger, 2005; Salway, 2004).  
Oxidixed glutathionine (GSSG) can incorporate selenite to become GS-Se-SG, 
and the latter then reduced to GS-SeH by gluthathione reductase. GS-SeH can 
reversibly convert to selenide upon GSH conversion to GSSG. GS-SeH, also will bind 
glycogen or carbohydrate group to produce the selenosugar A. Methylation of 
Selenosugar A (with SAM acting as the methyl group donor) produces selenosuger B. 
Selenosugar B is the principle Se metabolite when the body is in a low-toxic range of 
Se (Kobayashi et al., 2002). Selenide can be converted back to methylselenol by 
methylation, and the methylselenol will also be methylated into dimethylselenide, 
which will be further methylated into trimethylselenide. These three reactions 
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catalyzed by methyl transferase use S-adenosylmethionine (SAM) to donate the 
methyl group (Ganther et al., 1966; Hsieh and Ganther, 1977; Suzuki et al., 2006b). 
Methylselenol can be reduced to methyl-selenic acid through a reversible reaction 
with thioredoxin reductase (MOORE et al., 1964; Speranza et al., 1973; Arner and 
Holmgren, 2000). Toxic doses of Se is known to be excreted into urine in the form of 
trimethylselenide and exhaled in the form of dimethylselenide (Kobayashi et al., 
2002).  
The Se in inorganic selenite or selenate in the diet will either go into 
selenoprotein or be excreted in the form of methylated Se or selenosugar. However, 
Se in the organic form SeMet can be preserved in Se-containing proteins except for 
synthesis of selenoprotein or excretion. The preserved Se from organic Se will be 
used once the body is Se deficient or the requirement of Se is increased under stress 
conditions (Surai, 2002).  
Selenocysteine (SeCys) 
SeCys is directly incorporated into the polypeptide chains of selenoproteins 
(Böck et al., 1991). The existence of SeCys rather than cysteine increases the 
enzymatic activity of selenoproteins as much as 100- to 1,000-fold (Burk, 2002). 
Organic Se compounds are transformed to selenide through reductive cleavage of the 
C-Se bond by lyase reactions (Suzuki, 2005). In contrast to Cys, SeCys residues from 
selenoprotein degradation are not appreciably re-incorporated into proteins. Instead, 
they are degraded in the liver to selenide by β-lyase, with the Cys residue re-utilized 
for protein synthesis. Selenide is phosphorylated to selenophosphate, which will be 
transformed to SeCys on SeCys-tRNA (21
st
 aminoacyl-tRNA), and the 
selenocysteinyl residue is incorporated into selenoprotein sequences.  
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Incorporation of SeCys into selenoproteins requires five specific components. 
They are: a SeCys-insertion sequence element (SECIS) in the 3’-untranslated region, 
a SeCys codon (UGA) in the coding region, a SeCys-specific translation elongation 
factor, the SeCysSeCystRNA, and a SECIS-binding protein (SBP2) (Suzuki, 2005; 
Daniel and William, 2008).). The initial step in biosynthesis is the charging of serine 
on the specific tRNA
Sec
 by seryl-tRNA snythetase, followed by Ser-tRNAsec to Sec-
tRNA
sec
 conversion, which is catalyzed by SeCys synthase, an enzyme that utilizes 
phosphoserine as an intermediate to generate SeCys (Sturchler-Pierrat, et al., 1995). 
The whole process included three different steps: aminoacylation of tRNA
Sec
 with 
serine by seryl-tRNA synthetase; transformation of serine to phosphoserine; and 
conversion of phosphoserine to SeCys. The SECIS (SeCys insertion sequence) 
element is an RNA stem-loop structure that resides in the 3’UTR of selenoprotein 
mRNA. This SECIS element is mandatory for UGA recognition as Sec and not a stop 
codon (Aeby et al., 2009). A stem loop structure that resides 7 nucleotides distant 3’ 
to the UGA Sec codon is the Se response element (SRE). Presumably, the SRE can 
stimulate decoding of UGA (Nasim et al., 2000).  
A number of protein factors also are essential for selenoprotein synthesis. For 
example, EFSec (which binds only to the Sec-tRNASec) acts as the elongation factor 
for selenoprotein B (SelB) and nucleotlin and NSEP1 are coeffectors that bind SECIS 
(Lescure et al., 2002).  
Selenomethione (SeMet) 
The incorporation of SeCys into selenoproteins is known as the “regulated 
pathway” of Se incorporation into proteins because of the obligate SECIS genetic 
element (Suzuki, 2005). In contrast, the incorporation of Se into polypeptide chains 
through SeMet is known as the “unregulated” pathway (Papp et al., 2007) because 
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SeMet is directly incorporated into polypeptide chains. Furthermore, tRNAMet readily 
recognizes SeMet and does not distinguish between SeMet and Met (Cowie et al., 
1959; Burk et al., 2001; Suzuki, 2005). Because SeMet and Met share the same codon, 
the ratio of incorporation into proteins for SeMet is dependent on the SeMet:Met ratio 
in feedstuffs, and excessive SeMet supplementation increases this ratio and the 
incorporation content. Once proteins are synthesized, SeMet is retained at the pre-
synthesis ratio of SeMet:Met (Suzuki, 2005). Once SeMet is metabolized as a 
constituent of the Met pool, it is available to be incorporated randomly into cellular 
proteins and is unaffected by specific Se-metabolism processes (Burk et al. 2001). 
SeMet, however, can be metabolized to selenide through the trans-selenation pathway 
or through the direct lyase reaction. Thus, the non-specific incorporation of SeMet in 
place of Met in various proteins is a way of preserving Se for future use in the body 
(Zeng, 2009; Hall et al., 2012).  
The Se in SeMet can become available for regulated pathway-mediated 
selenoprotein synthesis when catabolized to selenide by γ-lyase, especially during 
periods of excessive SeMet intake (Behne, et al., 1992; Schrauzer, 2003). Then it 
shares the exact same pathway to synthesize selenoproteins as SeCys. Gamma-lyase 
activity also can yield methylselenol (CH3SeH), which has been identified as an anti-
cancinogenic agent from SeMet produced selenide, whereas β-lyase produces Se from 
MeSeCys during SeCys metabolism (Suzuki, 2005). Methylselenol is primarily 
excreted in breath and urine after conversion to TMSe (Gabel-Jensen et al., 2010) but 
may also enter the selenide pool via the reverse reaction by demethylase (Fairweather-
Tait et al., 2010). The presence of γ-lyases in the liver suggests that the liver is the 
primary site of SeMet degradation. 
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Inorganic Se 
The inorganic Se compounds selenite and selenate are commonly reduced to 
selenide for further utilization or excretion, but their primary routes of metabolism 
differ (Suzuki, 2005). For example, blood selenite is readily absorbed by red blood 
cells (RBCs) whereas selenate ions are absorbed by hepatocytes through a transport 
system for phosphate or excreted directly into urine (Suzuki, 2005). After absorption 
by RBCs, selenite is readily reduced to selenide, effluxed into blood, and bound by 
albumin for transfer to the liver. Subsequently, selenide and selenate are used by the 
liver for synthesis of selenoproteins through incorporation into SeCys (Suzuki, 2005), 
as described above.  
Selenoproteins 
Selenoproteins are defined as proteins which require SeCys incorporation into 
their polypeptide chains. There are 25 selenoprotein genes in humans, and SeCys 
residues were found in the active site of those that have been attributed a function 
(Allmang et al., 2009). Most selenoproteins function as peroxidases. The first 
mammalian protein identified as a selenoprotein was cytosolic glutathione peroxidase 
(GPX-1) (Allan et al., 1999). Additional glutathione peroxidase enzymes have been 
identified, including a glycosylated plasma glutathione peroxidase (GPX-2), a 
gastrointestinal glutathione peroxidase (GPX-3), and a phospholipid-hydroperoxide 
glutathione peroxidase (GPX-4) (Tham et al., 1998). Except for GPX-4, these 
peroxidases exist as tetramers, with each subunit containing one SeCys residue (Allan 
et al., 1999). The tetrameric forms catalyze the reduction of a variety of 
hydroperoxides, including hydrogen peroxide, cumene hydroperoxide, t-butyl-
hydroperoxide, and fatty acid hydroperoxides (Flohe 1989; Wiley et al., 1995). In 
contrast, GPX-4, a monomer that contains one SeCys residue, catalyzes the reduction 
of both fatty acid hydroperoxides and cholesterol hydroperoxides (Ursini et al., 1985). 
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After reaction with a peroxide substrate, regeneration of the reduced active form of 
the enzyme requires GSH (reduced glutathione). These selenoproteins have anti-
oxidative activities in the body, and glutathione peroxidase and thioredoxin reductase 
are thought to be the most abundant antioxidant enzymes in mammals (Gladyshev et 
at., 1998).  
Several selenoproteins, including selenoprotein P and W, and GPx 1, 3, and 4, 
have been used widely as biomarkers of Se status (Brown and Arthur, 2001). 
However, because selenoprotein P typically accounts for approximately half of the Se 
in plasma, reaches a plateau after 2-4 weeks of supplementation, and is well 
correlated with plasma Se across a wide range of Se status, it is often considered to be 
the best biomarker of Se status (Fairweather-Tait, et al., 2010).  
Excretion of Se  
Selenium is excreted in urine (50 – 60%), in feces, and expired. However, Se 
expiration only occurs when Se intake is extremely high (Suzuki, 2005). If toxic 
levels of Se are not absorbed, the major urinary metabolite of Se is selenosugar. Two 
different Se sugars have been identified: Se-glutathionyl-N-acetylselenohexosamine 
(selenosugar-A) and Se-methyl-N-acetylselenohexosamine (selenosugar–B) 
(Vadhanavikit et al., 1993; Kobayashi et al., 2002; Gammelgaard et al., 2008). 
Selenosugar-A is thought to be the precursor for selenosugar B. Selenosugars are 
thought to be produced principally by the liver, absorbed by kidney, then excreted 
into urine (Suzuki, 2005).  
However, if excessive Se is absorbed, it is excreted as methylated selenide in 
the urine, mon-, di- (DMSe) and trimethylselenonium (TMSe) (Ali and Aboul-Enein, 
2006). In addition, DMse is known to be exhaled (Vadhanavikit et al., 1993). The 
ratio of the two major Se metabolites in urine changes depending on the Se dose, i.e., 
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at a lower dose, Se is excreted mostly as monomethylated Se, whereas TMSe is the 
primary form of excretion when high levels of Se are consumed (Suzuki, 2005).   
Toxicological and Nutritional Markers 
Consumption of Se at or above a concentration of 2.0 μg/g diet or mL of 
drinking water are toxic (Suzuki, 2005). As discussed above, TMSe becomes the 
predominant form of Se excretion at these levels, at least in rats (Kobayashi et al., 
2002). Thus, selenosugars are assumed to be a nutritional marker for non-toxic Se 
consumption whereas TMSe may be a toxicological marker (Kobayashi et al., 2002).  
Ruminant Se Metabolism 
Metabolism of Se by ruminants has common and uncommon components with 
nonruminants.  
Absorption and transfer 
It has been reported that 
75
Se, as a selenic salt, was unabsorbed from the 
rumen, slightly absorbed from the abomasum, secreted into duodenum and jejunum 
with net absorption by the ileum (Wright and Bell, 1996). The absorbed Se was either 
bound to carrier proteins, or existed as a free form, for transport to the liver and other 
tissues. After absorption, Se metabolism in ruminants is similar to non-ruminants 
(Ceballos and Wittwer, 1996).  
Ruminant vs Nonruminant Se metabolism  
The absorption and availability of inorganic Se is very low for cattle, with 
only about 11 – 16% consumed being absorbed (Koenig et al., 1991; Koenig et al., 
1997) and about only 14% of that fed (136.9 of 973.3 µg/daily Se) was accumulated 
in the cattle body (Kamada et al., 1998). Accordingly, absorption of inorganic Se in 
ruminants is much lower than in monogastric animals. That is, absorption of orally 
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administered 
75
Se for sheep was less than half that by swine and rats (34% vs 85%) 
(Wright and Bell, 1966; Mason and Weaver, 1986), and the low net absorption and 
bioavailability of Se for ruminants has been attributed to Se metabolism by rumen 
bacteria (Kamada et al., 1998).  
One reason for this low absorption of inorganic Se for ruminants may be the 
Se-reducing conditions of the rumen and microorganisms influence. That is, rumen 
bacterial convert inorganic Se into insoluble forms such as metallic Se or selenides 
(Peterson and Spedding, 1963; Cousins and Cairney, 1961; Spears, 2003), which 
results in decreased rates of absorption. The fate of inorganic Se that is absorbed by 
microorganisms, is incorporation into microbial proteins (presumably as SeCys), thus 
providing a source of organic Se for digestion and absorption by the ruminant 
digestive tract. It has been shown that Se concentrations in bacteria isolated from 
sheep rumen is 2.3 and 3.9 times the original dietary Se concentration of the forage 
and concentrate diets, respectively (Koenig et al., 1997). Likewise, Se in the liquid 
phase of digesta was largely protein-bound and, following hydrolysis of the microbial 
cell protein, the element was absorbed as Se-containing free amino acids (Hidiroglou 
and Jenkins, 1974). It is known that 6 h post dosing, 50% of Se was present in rumen 
bacterial protein (Hidiroglou and Jenkins, 1974).  
Different species of bacteria in the rumen metabolize inorganic Se into 
different forms. For example, Selenomonas ruminantium can accumulate selenite into 
SeCys, selenoethionine, SeMet and red elemental Se. However, some bacteria such as 
Bacteroides ruminicola cannot incorporate selenite into organic compounds 
(Hudmann and Glenn, 1984; 1985). In addition, the overall availability of inorganic 
Se incorporated into bacterial proteins is very low, which means that a lot of inorganic 
Se is unavailable for ruminant metabolisms. In contrast, the organic Se containing 
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amino acids can be used for available Se directly. From this perspective, organic Se is 
more bioavailable for for ruminants than inorganic forms.  
The effect of Se supplementation on rumen bacterial fermentation 
Dietary Se supplementation can affect rumen conditions and metabolism, 
especially rumen microbial fermentation (Kim et al., 1997). It was reported that 
rumen gas production was positively correlated with supplemented Se between 0.2 
and 0.4 mg Se/kg dietary dry matter, and short chain fatty acid production was 
optimal at 0.2 and 0.4 mg Se/kg dry matter but decreased significantly for 
concentrations greater than 12.8 mg Se/kg dry matter (Von Brehm, 2001).  
Excretion  
Excretion of Se by cattle is through urine, feces, and exhalation. When Se is 
administered via intravenous or subcutaneous injection of ruminants, urine is the 
major route of excretion (Wright and Bell, 1966). The other principal route of Se 
excretion in ruminants is the feces (Wichetel, 1998; Neathery et al., 1990; Podoll et al., 
1992).  
Tissue specific Assimilation of Se  
In mammals, Se is incorporated into red blood cells at time of their formation; 
therefore, taking into account their  life span (90-120 days) Se content of erythrocytes 
reflects Se intake 1-3 months previous (Smith et al., 1997; Smith et al., 1998). It is 
generally accepted that Se concentration in serum or plasma reflects short-term Se 
nutritional status, whereas whole blood (erythrocyte) Se and GSH-Px activity are 
more indicative of long-term Se status (Thompson et al., 1998).  
Se preferentially accumulates in tissues such as endocrine glands, brain, and 
reproductive organs (Allan et al., 1999). In the liver, dietary Se is metabolized to 
selenide and then incorporated as SeCys into selenoprotein P, the physiological form 
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that distributes Se from the liver to peripheral tissues and other organs (Dumont et al., 
2006). The kidney can synthesize the other major plasma selenoprotein, GPX3. In the 
liver and kidney, cellular GPx was detected as the carrier of endogenous Se (Suzuki 
and Ogra, 2002). Many tissues can indiscriminately incorporate SeMet into proteins 
in competition with Met, and both the liver and extra-hepatic tissues have been 
predicted to metabolize SeMet to multiple end products with the potential for 
biological activity. The inter-tissue (liver, kidney, serum, and urine) distribution of 
selenite and selenate Se was determined after intravenous injection (Suzuki and Ogra, 
2002). Red blood cells take up selenite and selenite is reduced by glutathione to 
selenide, which was is transported to plasma, selectively bound to albumin, and 
transferred to the liver (Shiobara and Suzuki, 1998).  
Manipulation of Inorganic Versus Organic Se Metabolism  
Organic versus inorganic Se tissue assimilation 
It is generally accepted that tissue assimilation of organic Se is greater than 
assimilation of inorganic Se in cattle. Serum Se concentrations tended to be uniformly 
higher during and at the end of the trial in beef cattle given Se yeast compared to 
selenite (Fisher, 1995; Fisher et al., 1995). The supplementation of organic versus 
inorganic Se (0.2 mg/day) for 8 weeks to Se-deficient cattle resulted in increased 
blood Se of 5.6 to 167 (Se-yeast) per µg/L versus91 µg/L (selenite) (Malbe et al., 
1995). Selenium (0.75 mg daily) from the Se-yeast maintained Se concentrations in 
whole blood and milk at the same levels as Se 3.0 mg in the form of sodium selenite 
and Se (3.0 mg) from the yeast product increased blood Se by 40% and that in milk by 
100%, compared to the equivalent amount of inorganic selenite (Ortman and Pehrson, 
1997). The Se concentration in plasma was 1.26 fold higher for heifers supplemented 
with Se-yeast compared to sodium selenite (Weiss, 2003). Furthermore, a 20 to 30% 
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increase in whole blood Se levels was associated with organic Se supplementation 
(Sel-Plex, Alltech, Inc.) compared to inorganic Se (Eliott et al., 2005).  
Organic Se versus inorganic Se on Se bioavailability  
Because serum Se concentration can reflect the GSH-Px activity of beef cattle, 
the serum Se concentration was used as the value to measure the bioavailability of Se 
in beef cattle. It should be mentioned that dietary Se is highly correlated to GSH-Px 
when animals are deficient in Se, but the relationship weakens as animals become 
adequate in Se (Stadmore et al., 1982; Combs and Combs, 1984; Kincaid, 1999; Rock 
et al., 2001). Thus, after reaching a certain concentration of Se in the blood, which is 
necessary for maximum expression of GSH-Px, there is no further increase in the 
enzymatic activity of GSH-Px. 
In general, the bioavailability of organic Se was superior to inorganic Se. The 
relative bioavailability (selenite=1) of yeast Se was 1.4 if blood GSH-Px, 1.9 if blood 
Se, and 2.7 if milk Se was used as the response criterion (Malbe et al., 1995). The 
bioavailability of Se (GPx activity in the erythrocytes) for Se-deficient heifers 
supplemented with Se-containing yeast for 12 weeks was about twice that than for 
heifers supplemented with equal amounts of inorganic sources (Na or Co selenite) 
(Pehrson et al., 1989).  
Genotype can also affect the Se bioavailability. The Se bioavailability 
response by humans after 6 wk of Se supplementation with 100 μg sodium selenite/d 
was  influenced by genetic polymorphisms in the selenoprotein P (SEPP) and GPX4 
genes. These biomarkers (plasma Se, selenoprotein P, and GPx3) that used to assess 
Se bioavailability were associated with 2 common single nucleotide polymorphisms 
in SEPP in both baseline and post-supplementation samples, and the GPX4 
polymorphism was shown to influence lymphocyte GPx4 concentration and other 
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selenoproteins in vivo (Meplan et al., 2007). A single nucleotide polymorphism in 
GPx1 was associated with Se deficiency and impaired GPx1 activity (Lei et al., 2009) 
and also may be associated with a different response of GPx1 activity to Se 
(Jablonska et al., 2009). It is possible that common polymorphisms in selenoprotein 
genes, such as SEPP, GPX1, GPX4, and selenoprotein S (SELS) will have a 
significant effect on the metabolism of dietary Se and will generate differences in 
bioavailability. This possibility warrants further investigation.  
Organic versus inorganic transfer of Se into colostrum and milk 
It is well known that cattle have a limited ability to transfer Se into colostrum 
and milk when sodium selenite is used as a dietary supplement. It was found that 
organic Se in the ruminant diet contributes to higher Se concentration in colostrum 
and milk, which could help to build antioxidant system of newborn calves through the 
antioxidant activity of Se (Slavik et al., 2008).  
It was reported that Sel-Plex supplemented diets had 67% higher milk Se 
content within 2 weeks of initiating supplementation than when sodium selenite was 
supplemented. Furthermore, somatic cell counts were significantly reduced 30% as 
early as 2 weeks after inclusion of Sel-Plex, and that this trend continued throughout 
the 6 week supplement period (Duarte et al., 2004). Similarly, inclusion of Se (0.2 
ppm) in the form of sodium selenite (0.2 ppm) into the cattle diets provided 2.2 mg 
Se/day for 8 weeks was associated with an increased Se level in milk (0.138 mg/L 
versus 0.048 mg/L) and decreased somatic cell counts (174,500 versus 229,300) 
cells/mL (Foltys et al., 2004). The inclusion of Sel-Plex Se in cattle diets at 2 or 6 mg 
Se/day was associated with increased Se concentration in the milk from 6.9 up to 15.0 
and 25.2 ng/ml, respectively, compared to inorganic Se (McIntosh and Royle, 2002). 
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The replacement of sodium selenite with Sel-Plex also has been associated 
with a significant increase in Se concentration in colostrum from 2.67 to 6 mg/day, 
and was associated with an increase in Se concentration in colostrum after the first 
two milkings by 42%, and after the first 8 milkings by 35% (Lewis, 2004). Others 
found that only 4.8% of Se was transferred to milk if sodium selenite was added, 
whereas 19% of the Se appeared in milk if organic Se was fed (Waite et al., 1975; 
Conrad and Moxon, 1979) and that the efficiency of Se transfer to milk of cattle fed 
Se-yeast ranged from 9.9 to 12.5%, compared with 2.4-4.1% for cattle fed sodium 
selenite (Givens et al., 2004).  
Differential Organic Versus Inorganic Se Form Effects on Immune and Health 
Status 
Many experiments have reported that organic Se supplement can contribute to 
higher Se concentrations in blood, liver, and milk, accompanied by improvement of 
animal quality, in particular with improved immunity and health. It was shown that 
organic Se supplementation of cattle diets could maintain high Se status during all 
periods of ontogenesis and to maintain high productive and reproductive 
performances in stress conditions of commercial meat and milk production (Lyons et 
al., 2007). Experimental data have included a number of observations such as: 
increased GSH-Px activity in erythrocytes, decreased somatic cell counts, improved 
health, and production and reproduction parameters in cattle supplemented with 
organic Se (Cortinhas et al., 2010).  
During stress, the activity of proteosomes increase to provide amino acids 
needed for the formation of immune defense cells and enzymes, including Se-
dependent GSH-Px and thioredoxin reductases (Surai, 2006). During such times, 
SeMet in proteins can be released y protein catabolism, thus providing a source of Se 
needed for synthesis of GSH-Px and other selenoenzymes. Because the SeMet can be 
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incorporated as “Met” through the non-regulated pathway, SeMet can be re-used 
(Suzuki, 2005).  
The advantages of organic Se supplementation compared to inorganic Se 
include: 1. higher concentration of Se in the blood, milk, and tissues of cattle with Se-
yeast compared to inorganic Se supplement; 2. long-term supplementation of cattle 
dies with Se-yeast does not result in toxic accumulations of Se, 3. beef calves whose 
dams were supplemented with Se-yeast had a higher Se status than calves whose 
dams were supplemented with selenite (Surai, 2006); 4. Se-yeast proved to be more 
effective in stimulating weight gains and liver Se concentrations than sodium selenite 
(Surai, 2006); 5. Se-yeast was more effective than sodium selenite in raising and 
maintaining adequate Se concentrations in tissues of beef cattle (Ortmana, 1999; Valle, 
2001). 
Overall, dietary Se supplementation in inorganic forms does not appear 
adequate to meet high Se demand of growing, reproducing, and lactating animals, and 
is less than adequate for further metabolism due to reduction to metallic Se or selenide 
by rumen bacteria and much lower retention level than organic Se. The feeding of 
organic Se, such as selenized yeast, results in increased Se concentrations in blood 
and GSH-Px activity. For example, Se concentration is doubled in colostrum and milk, 
and the Se transfer through placenta is greater when Se supplied as OSe than ISe 
(Surai, 2006). As a result, cattle health is improved with lower somatic cell counts, 
decreased mastitis and retained placenta and improved conception rates. The benefit 
to newborn calves is due to improved antioxidant defense and thermoregulation 
leading to better immunity, viability and lower mortality during first months of the 
postnatal development. It is also beneficial that organic Se SeMet can build Se 
reserves in their tissues, in particular in muscles and those reserves can be effectively 
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used by cattle in stress conditions when Se requirement is increasing while feed 
consumption is declining (Surai, 2006). 
Effect of Se supplements on Aspects of Beef Cattle Physiology 
The effect of supplementation of Se for beef on blood Se concentration and 
GSH-Px activity, selenium status in their calves, and immune status has been studied. 
Supplementation of Se has higher Se concentration and GSH-Px activity than non-
supplemented beef. Cattle provided supplemental 2.5 mg/d Na selenite or Se-yeast 
(Sel-Plex; 2.5 mg/ d) had greater liver and plasma Se concentrations and greater 
plasma GSH-Px activity compared with control steers on day 60 and 90 (Arthington, 
2008). Copper and Se supplementation to cattle maintained GSH-Px activity within 
normal range, compared to the non-supplemented animals that had GSH-Px activity 
was below the normal range (Minatel et al., 2002). Both 1.7 mg supplemental Se/d as 
sodium selenite and Se yeast increased blood Se concentrations of beef calves 
compared to the non-supplemented group (Fry et al., 2005).  
Selenium content was positively correlated with the GSH-Px activity and 
antioxidative ability. The mean value of Se concentration in whole blood and GSH-Px 
activity of calves fed a basal diet and a ready-made fodder mix that contained 0.1 
mg.kg
(-1)
 selenium were higher than the non-supplemented group and was correlated 
with Se concentration in whole blood and GSH-Px activity (Harapin et al., 2000). 
Examination of blood serum and meat samples of clinically healthy Limousine and 
Angus calves grazed on grass pasture was negatively correlated with blood serum 
repetitive strain injuries and selenium content, which means a positive effect of Se 
content in beef on the protective antioxidative processes in blood serum (Matthes et 
al., 2002). However, even though supplementation of Se leads to increased serum and 
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tissue Se concentrations, these differences may not be concomitant with altered 
animal performance (Richards and Loveday, 2004).  
Supplementation of beef cows with Se can maintain Se content and GPH-Px 
activity and immune response for their calves. At 180 d after birth, blood Se 
concentrations for calves of dams subject to no Se supplementation during day 115-
130 of gestation were deficient (<50 µg Se/L), but Se yeast supplementation maintain 
an adequate Se level (188 µg of Se/L), and the liver Se content of calves was greater 
of supplemented group than control group (Davis et al., 2005). Supplementation with 
Se of pre-weaning calves increased whole blood Se concentration and GSH-Px and 
tended to increase in vivo cell-mediated immune response compared to Se deficient 
non-supplemented calves at 22 day after weaning (Beck et al., 2005). Also, placental 
transfer of Se is more efficient than milk transfer for calves from cows that received 
Se supplementation (Enjalbert et al., 1999).  
Supplementation of Se can decrease infectious disease challenge and promote 
antibodies in response to antigen challenges. Titers of infectious bovine 
rhinotracheitis virus in steers increased from d 0 to 7 after the infectious challenge and 
decreased from day 7 to 21 in the Sel-Plex and selenite steers but continued to 
increase through 21 d after the challenge for non-supplemented steers (Covey et al., 
2010). Also, it was reported that although supplementation of 1.7 mg Se/d had 
minimum effects on immune function of weaned beef steers (Fry et al., 2005), blood 
Se levels over 100 mg L
-1
 are needed to maintain optimum immunocompetence 
(Nicholson et al., 1993).  
The effect of organic versus inorganic Se supplementation on bioavailability 
and immunocompetence in beef cattle has been initially evaluated. The 
supplementation of organic Se to diets of weaned beef steers increased Se content and 
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GSH-Px than inorganic Se (Fry et al., 2005). Supplementation of organic Se resulted 
in more available Se for calves than inorganic Se. Organic Se supplementation also 
resulted in higher immunocompetence than inorganic Se. Also,supplementation of Se-
yeast of pre-weaning calves increased macrophage phagocytosis compared with 
sodium selenite (Beck et al., 2005). The ability of yearling beef cattle supplemented 
with Se to produce antibodies in response to antigen challenges with sheep red blood 
cells and ovalbumin tended to be higher for Se-enriched yeast than inorganic Se 
supplemented cattle (Nicholson et al., 1993). This greater effect by organic Se versus 
inorganic Se in ruminants could be a result of the rumen microbial reducing 
conditions converting inorganic Se into low available insoluble forms. However, 
without conversion, the organic Se can be used directly.  
In summary, dietary Se supplementation in inorganic form is not adequate to 
meet high Se demand of growing, reproducing and lactating animals, and is less than 
adequate for further metabolism because of reduction to metallic Se or selenide by 
rumen bacteria, resulting in much lower retention level than organic Se. The organic 
Se such as selenized yeast in the form of Sel-Plex is better than inorganic Se due to 
increased Se concentration in blood and GSH-Px activity, approximately doubled Se 
concentration in colostrum and milk, higher Se transfer via placenta. As a result, cattle 
health is improved with lower somatic cell counts, decreased mastitis and retained 
placenta as well as improved conception rates. The benefit to the newborn calves is 
due to improvement of their antioxidant defenses and thermoregulation leading to 
better immunity, viability and lower mortality during first months of the postnatal 
development. It’s also beneficial that organic Se SeMet can build Se reserves in their 
tissues, in particular in muscles and those reserves can be effectively used by cattle in 
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stress conditions when Se requirement is increasing while feed consumption is 
declining. 
Effects of Se Supplementation on Hepatic Gene Expression  
Selenium supplementation increased the expression of genes involved in 
antioxidant defense, lesion-protection, and apoptosis under the tumorigenesis. cDNA 
array showed that Se deficiency in rats led to a down-regulation of Se-dependent 
cGPx, significant down-regulation of genes important in the inhibition of apoptosis 
(defender against cell death 1 protein, Bcl2-L1), cell cycle (G1/S-specific cyclin D1) 
and antioxidant defense (gamma -glutamylcysteine synthetase catalytic subunit). 
Furthermore, an induction of genes encoding for detoxifying enzymes in liver 
(cytochrome P450 4B1, UDP-glucuronosyltransferase 1), and combined vitamin E 
and Se deficiency affects the expression level of genes encoding for proteins involved 
in inflammation (multispecific organic anion exporter, SPI-3 serine protease inhibitor) 
and acute phase response (alpha-l acid glycoprotein, metallothionein 1) ( Fischer et al., 
2001). Dietary Se deficiency decreased mRNA levels of 7 common genes (Gpx1, 
Gpx4, Sepw1, Sepn1, Sepp1, Selo, and Selk) coding for selenoproteins involved in 
oxidation- and/or lesion-protective effect in liver of chicks (Huang et al., 2011). Se-
supplemented diets also increased expression of SelW and selenocysteine-synthase in 
the liver of chickens compared to non-Se-supplemented chickens (Sun et al., 2011). 
Supplementation of Se for 2 weeks to rats reduced protein kinase c-alpha (PKC-alpha) 
gene overexpression in preneoplastic liver and the formation of preneoplastic lesions 
in the liver (Chen, 1993). Furthermore, 2.1 mg Se/kg Se-enriched broccoli diets for 10 
weeks increases and ikBalphakappaB, hsp86, gadd45 gene transcripts and activates 
pro-apoptotic genes linked to p53, NFkappaB in response to "danger signals" such as 
tumorigenesis to the liver of rats compared to 0.11 mg selenium/kg control diet (Zeng 
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et al., 2003). The increased antioxdative capacity induced by those genes could 
explain the better immune-competence for Se supplemented beef cattle.  
As for genes involved in iron metabolism, the expression of transferrin, 
transferrin receptor, and iron regulator protein1 mRNA were more abundant in Se-
deficient (non-supplemented Se) than in Se-adequate (0.15 mu g Se/kg as sodium 
selenite for 15 wk) liver (Christensen et al., 2000). In addition, supplementation of Zn 
and Se can protect against Cd-induced toxicity by alteration of metallothionein gene 
expression in the liver of rats (Banni et al., 2010).  
The mRNA levels for transthyretin and citrate transport proteins are both 
reduced in the livers of Se-deficient rats compared to Se supplemented rats with 0.5 
mg Se/kg diet for 13 weeks (Kendall and Christensen 1997). The solute carrier gene 
Slc48a1 is up-regulated in the liver of rats with selenium-deficient diets compared to 
selenium-supplemented diets (Mallonee et al., 2011).  
Other genes found to be differentially expressed upon Se supplementation 
compared to non-Se supplementation are involved in other metabolic pathways. The 
mRNA levels for liver estrogen sulfotransferase isoform-6 alpha 2u-globulin were 
markedly reduced in Se deficiency compared to rats supplemented Se with 0.5 mg 
Se/kg diet as sodium selenite to the rats for 13 weeks (Yang and Christensen 1998). 
Furthermore, 50 g/kg Se supplementation for 60 days down-regulated the expression 
of phospholipase D mRNA in the liver of diabetic rats compared to non-supplemented 
rats (Wu et al., 2006).  
Organic and inorganic Se supplementation also differentially affects the gene 
expression of liver. Genes in the liver of mice related to the selenoproteins Gpx1, Selh, 
Sep15, and Sepw1, were differentially expressed among Se supplemented diets 
(sodium selenite, SeMet, or a yeast-derived Se) (Mallonee et al., 2011). Also, in mice, 
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non-selenoproteins encoded by Se-responsive genes including transport and stress 
response are differentially induced by three Se supplemented diets (Mallonee et al., 
2011). Because most of selenoproteins function as peroxidases, the different 
expression of genes related to selenoproteins, and some genes related stress response, 
upon organic versus inorganic Se supplements could explain the different 
antioxidative capacity of beef cattle supplemented with organic forms of Se. 
In summary, Se supplementation has different effects on the expression of 
genes in the liver compared to non-supplements. Differentially expressed genes are 
involved in 1) oxidation/lesion, apoptosis; 2) iron metabolism; 3) carrier proteins and 
transporters; 4) other metabolisms.  
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Chapter 3: Hepatic transcriptome profiles differ among maturing beef heifers 
supplemented with inorganic, organic, or mixed (50% Inorganic:50% Organic) 
forms of dietary selenium 
Introduction 
Selenium is a metalloid belonging to Group VIA of the Periodic Table, the 
same as sulfur. Selenium plays an important role in regulation of various 
physiological functions in beef cattle including immunity, reproduction and early 
postanatal viability (Suzuki, 2005). Selenium deficiency alone, or in combination with 
vitamin E, is associated with reduced growth and productivity rates, early mortality 
and immune-suppression. Se deficiency has been specifically linked with the 
development of various diseases in ruminants (Pehrson, 1993; Kolb and Seehawer, 
2001) including nutritional muscular dystrophy (white muscle disease, the most well 
documented disease related to Se/vitamin E deficiency in ruminants), retained 
placenta and metritis (affecting about 9% of USA dairy industry births), and mastitis 
(estimated annual cost is $17,500 for a 100-cow herd) (Surai, 2006).  
The concentration and availability of Se in the soil primarily determines the Se 
content of forages .The Se requirement for beef cattle among all ages is 0.10 mg 
Se/kg of diet daily (NRC, 2000). The Se content in forages (and grains) of the 
southeast USA (including Kentucky) is low (＜ 0.05 mg Se/kg) to variable (＜ 0.1 
mg/kg) (Ammermann et al., 1975). Consistently, a survey of whole blood Se 
concentrations of beef cows and heifers from 253 cow-calf operations in 18 states 
found that 42% of southeastern USA (including Kentucky) cattle were Se deficient 
(≤0.080μg/mL), as opposed to 18% nationally (Dargatz and Ross, 1996). Therefore, 
Se supplementation of forage-based diets is necessary in Kentucky.  
Supplementation of diets with Se is regulated by the Food and Drug 
Administration and cannot exceed 120 mg Se/kg, or an intake of 3 mg per day, when 
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delivered in free-choice mineral supplements to cattle (FDA, 1987). Diets can be 
supplemented with inorganic or organic forms of Se.  Sodium selenite and sodium 
selenate are the typical forms used, despite the knowledge that Se primarily is present 
in plants as organic forms. Organic forms of Se include selenomethionine (SeMet) 
and selenocysteine (SeCys). However, commercial animal diets are not directly 
supplemented with SeMet or SeCys. Instead, SeCys and SeMet are supplied as 
constituents of Se-enriched yeast extracts (e.g., SeMet is the predominant form of Se 
in Sel-Plex (Alltech Biotechnologies, Inc., Nicholasville, KY) (Korhola et al., 1986).  
The effect of supplementing diets with inorganic versus organic Se 
supplements on Se bioavailability (concentrations of Se in blood and tissues) and 
bioactivity (blood glutathione peroxidase activity) have been compared. For example, 
assimilation of Se after 105-106 days by whole blood, red blood cells, and biopsied 
liver tissue was greater for slow maturing beef heifers fed 3 mg/day of Se as Sel-Plex 
than for sodium selenite (Liao et al. 2011). Similarly, Se concentrations (µg/g) in the 
skeletal muscle of cows supplemented with 3 mg/day as Se-yeast was 1.5-2.5 fold 
higher than when supplemented with sodium selenite (Ortman and Pehrson,1999).    
With regard to the effect of organic versus inorganic Se on animal 
performance under stress conditions, supplementation of Se in organic forms is 
known to decrease the mean milk somatic cell counts more than inorganic forms in 
experimental (McIntosh et al., 2002) and commercial (Harrison et al., 2005) cow 
herds. However, supplementing cattle diets with organic versus inorganic forms of Se 
did not affect the average daily gain of heifers supplemented with 3 mg Se/day as 
sodium selenite or Sel-Plex
® 
for 105-106 days (Liao et al., 2011). Likewise, there was 
no difference on the final body weight, average daily gain, or gain-to-feed ratios of 
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slow maturing beef heifers supplemented with 3 mg Se/day as sodium selenite, Sel-
Plex, or a 1:1 mix of  sodium selenite and Sel-Plex for 224 days (Brennan et al., 2011). 
To better understand effect of supplementing beef cattle diets with different 
forms of Se on hepatic function and hepatic Se-specific metabolism, so that 
appropriate dietary Se supplementation regimens for beef cattle can be developed, it 
would be usefull to understand if hepatic gene expression profiles differed in beef 
cattle fed the same diet but containing different forms of Se supplement. Achieved 
differences in small RNA (mRNA, miRNA) profiles would be indicative of altered 
physiological capacities. Our previous study examining the effects of organic versus 
inorganic 3 mg Se/day supplementation for 105 - 106 days on hepatic gene expression 
profile of beef cattle (Liao et al., 2011) revealed that organic and inorganic Se 
supplements commonly and differentially affected the hepatic gene expression 
compared to non-supplemented animals. These Se form-induced differences 
corresponded with 18 and 59% increases in hepatic content of Se by the inorganic and 
organic Se supplements. However, because only a single sample point (day 105/106) 
was used, it was not known if stabilization of hepatic Se assimilation had been 
achieved. Thus, conclusions about whether observed Se form induced difference in 
liver gene expression profiles represented stable or transient changes could not be 
drawn. 
To address this issue, and to determine the effect of a mix of inorganic and 
organic forms (Mix) consisting of 1.5 mg Se/day as sodium selenite and 1.5 mg 
Se/day as Sel-Plex
®
, a second experiment using the same animal model (maturing 
beef heifers gaining 0.5 kg/day on a cottonseed hull-based diet) was conducted over a 
224-day period using (n = 10) none (Control) or 3 mg Se/day dietary supplement 
treatments as sodium selenite (ISe), Sel-Plex (OSe), or Mix to determine the effect of 
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Se supplement form on tissue assimilation of Se (Brennan et al., 2011). Se 
assimilation (µg/g) by liver tissue of ISe, OSe, and Mix treatment heifers was 
maximal and stable from d 56 throught d 224 for all treatment groups, but the amount 
of Se assimilated by liver tissue was dependent on the Se treatment (OSe = Mix > ISe > 
non-supplemented Control heifers). 
Using the liver tissue collected from these (Brennan et al., 2011) maturing 
beef heifers that had assimilated Se supplement form-specific amounts of Se, the 
objectives of the current work were to (1) compare hepatic gene transcriptome 
profiles when hepatic liver assimilation was stable (d 168) using microarray methods, 
and (2) conduct bioinformatics analysis of these profiles to predict altered hepatic 
physiological capacities induced by specific forms of Se supplement. 
MATERIALS AND METHODS 
Source of Liver Tissue, Experinetal Treatments, and Liver Se Concentrations 
The liver tissue samples used were from the animals of the Brennan et al. (2011) trial, 
for which all animal procedures were approved by the University of Kentucky 
Institutional Animal Care and Use Committee. Specific descriptions of the animal 
model (Brennan et al., 2011) and liver biopsy procedures used (Brown et al., 2009; 
Brennan et al., 2011) have been described. However, briefly, at the end of a common 
Se depletion period and diet-adaptation period, heifers were ranked (in groups of four) 
on the Se concentration of their biopsied liver sample. Within a rank, heifers were 
randomly assigned (n=10/treatment) to one of four dietary Se supplementation 
treatment groups, to stratify similar basal liver Se content among treatment groups. 
For the control treatment (Control) no exogenous source of Se was supplied to the 
basal mineral-vitamin premix. For the ISe, OSe, and a 1:1 combination of ISe and 
OSe (Mix), the basal mineral-vitamin premix was supplemented with sodium selenite 
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(ISe, Prince Se Concentrate; Prince Agri Products, Inc., Quincy, IL, USA), Se-
enriched yeast (OSe, Sel-Plex
®
, Alltech Inc., Nicholasville, KY, USA), or their 
combination, respectively. The Control, ISe, Mix, and OSe mineral-vitamin pre-mixes 
contained 1.09 mg/kg, 36.1 mg/kg, 34.74 mg/kg and 34.56 mg/kg of Se, respectively. 
Animals were weighed biweekly and intake of the basal diet adjusted, to ensure 
animals maintained an average daily gain of 0.5 kg/day. The daily supply of Se for 
each of the ISe, Mix, and OSe treatment rations was calculated to provide 3.0 mg/day.  
After biopsy, the liver sample from each animal was placed in foil packs, 
snap-frozen in liquid nitrogen, and stored at -80°C until analyzed for Se concentration 
or RNA extraction. The liver Se concentrations were analyzed as previously reported 
(Brennan et al., 2011) by Donald C. Mahan (The Ohio State University, Columbus, 
OH, USA) and differences in Se-form treatments reported (Brennan et al., 2011). 
Specifically, Se concentrations in liver were greater (P ≤ 0.01) in all three Se-
supplementation treatment groups than the non-supplemented Control group, whereas 
liver Se concentrations of Mix heifers were greater (P = 0.01) than for ISe heifers, 
OSe heifers tended (P =  0.08) to be greater than ISe heifers, and Mix heifer liver Se 
concentrations did not differ (P =  0.20) from OSe heifers (Brennan et al., 2011). 
RNA Extraction and Analysis 
For each animal, total RNA was extracted from 400 mg of frozen liver tissue 
using TRIzol Reagent (Invitrogen Corporation, Carlsbad, CA) following the 
manufacturer’s instructions.  The purity and concentration of total RNA samples was 
analyzed by a NanoDrop ND-1000 Spectrophotometer (NanoDrop Technologies, 
Wilmington, DE), which revealed that all samples were of high purity with 260/280 
absorbance ratios of 2.0-2.1 and 260/230 absorbance ratios ranging from 1.5 to 1.9.  
The integrity of total RNA was examined by gel electrophoresis using Agilent 2100 
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Bioanalyzer System (Agilent Technologies, Santa Clara, CA) at the University of 
Kentucky Microarray Core Facility.  Visualization of gel images and 
electropherograms showed that all RNA samples had high quality with RNA integrity 
numbers (RIN) being greater than 8.8 and 28S/18S rRNA absorbance ratios greater 
than 1.8.  
Microarray Analysis 
The custom WT Btau 4.0 Array (version 1) (GeneChip; Affymetrix, Inc., 
Santa Clara, CA), which contains 26,303 bovine gene transcripts, was used.  
Microarray analysis was conducted according to manufacturer’s standard protocol at 
the University of Kentucky Microarray Core Facility.  Briefly, 3 g RNA for each 
sample was reverse-transcribed to cDNA first, and then from cDNA (double-stranded) 
to cRNA (single-stranded) which were then labeled with biotin.  The biotinylated 
cRNA were further fragmented and used as probes to hybridize the GeneChips in the 
GeneChip Hybridization Oven 640, using 1 chip per RNA sample.  Due to the loss of 
one animal, and failure to obtain one liver sample, the experimental observations for 
each treatment were as follows: n = 9 (one missed sample), 9 (one animal died), 10, 
and 10 for Control, ISe, Mix, and OSe treatments, respectively. 
The raw expression intensity values from the 38*.cel files from the raw 
methylation measurements were imported into Partek Genomics Suite software (PGS, 
version 6.66 beta; Partek Inc., St. Louis, MO). For GeneChip background correction, 
the algorithm of Robust Multichip Averaging adjusted with probe length and GC 
oligo contents was implemented (Irizarry et al., 2003; Wu et al., 2004). The 
background-corrected data were further converted into expression values using 
quantile normalization across all the GeneChips and Median Polish summarization of 
multiple probes for each probe set (Partek, 2009). The similarity matrix was generated 
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by Pearson (Linear) Correlation and was converted to heat map to visualize the 
correlation among chips. One Mix and one OSe treatment chip were identified as 
outliers because of their relatively low correlation with any of other GeneChips. The 
average correlation between any pair of GeneChips 38 was 0.975 except for two of 
the chips (one belonged to Mix, and one to OSe) that had correlations of about 0.943 
and 0.837 with the other chips (Figure 1a). These two chips were removed prior to 
further statistical analysis. New correlation heat map (Figure 1b) after removing 
outliers showed no outliers, the final correlation meets the 0.984. The remaining 36 
*.cel files (n=9 for each of the Se treatments) were imported into PGS and subjected 
to the background correction and normalization as decided above.  
GeneChip transcripts were annotated using the NetAffx annotation database 
for Gene Expression on Bovine GeneChip Array, provided by the manufacture and 
last updated September 2011. When appropriate, incompletely annotated transcripts 
were subjected to GenBank analysis and annotation updated.  Quality control of the 
microarray hybridization and data presentation was performed by MA-Plot on all 
gene expression values and Box-Plot on the control probe sets on Affymetrix 
GeneChips (data not shown).   
Principle component analysis (PCA) was conducted to determine the quality 
of the microarray hybridization and visualize the general data variation among the 
chips (Partek, 2009). Differentially expressed genes (DEG) were subjected to 
hierarchical clustering (Partek, 2009) and Ingenuity Pathway Analysis (IPA, 8.7-3203; 
http://www.ingenuity.com; Ingenuity Systems, Inc., Redwood City, CA). 
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MicroRNA analysis 
Selected microRNA (miRNA) were imported into the miRNA database 
(http://www.mirbase.org/index.shtml) to search and browse their hairpin precursor 
and mature sequences, and their annotation, including accession or ID or pubmed ID. 
To predict their targets, miRNA sequences were imported into the TargetScan 
(http://www.targetscan.org). The biological targets of Bos taurus miRNA were 
identified by searching for the presence of (1) conserved branch length sites that 
matched the seed region of each miRNA (Lewis et al., 2005), (2) sites with 
mismatches in the seed region that are compensated by conserved 3’ pairing 
(Friedman et al., 2009), (3) and poorly conserved sites. Putative miRNA targets were 
compared to DEG found to be affected (P < 0.01) by Se treatment. The DEG that 
were putative targets of miRNA were subjected to the miRNA Target Filter analysis 
component of IPA. 
Statistical Analyses 
Animal was the experiment unit and one GeneChip per animal was used to 
evaluate relative hepatic mRNA content in response to Se treatment. Se treatment 
effects on expression of all 26,303 array transcripts were determined by ANOVA. 
Source of variation analysis determined the sources of variation associated with 
treatment and error by calculating the mean F ratio of all 26,303 transcripts by Partek 
Genomic Suite (6.66 beta version) software. Gene transcripts were considered 
differentially expressed at P < 0.01. Treatment least square means of DEG were 
separated using the pdiff option of SAS (9.2 version, SAS Inst., Inc., Cary, NC, USA).  
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RESULTS 
Principle Compent Analysis (PCA)  
The mean F ratios for treatment and error were 0.90 and 1.00, respectively 
(data not shown). Principle component analysis revealed a total variance of 16.7% 
(Figure 2). The principal component (PC #1, x-axis) contained transcripts with a 
higher degree of variance 9.08%, whereas PC #2 (y-axis) encompassed genes that had 
lower 7.58% ranges of variance. In general, the GeneChips within each treatment 
group were clustered together and the Control, OSe, and Mix treatment groups were 
clustered closer than the ISe.  
Se Treatment-specific Profiles of Differentially Expressed Genes (DEG) 
Analysis of variance analysis found that the expression of 139 transcripts were 
differentially affected (P < 0.01) by Se supplementation (Table 1). Of the 139 DEG, 
the nucleotide or protein sequences have been validated. The range for Se treatment 
induced expression of annotated genes renged from 2.67-fold upregulated (BOLA-
DQA20) to 1.65-fold downregulated (MIR2393). Among these 139 DEG some were 
uniquely and some commonly affected by Se treatment (Figure 3). Relative to 
expression by Control heifers, 32 genes were solely affected by ISe treatment, with 
another 22 and 4 being commonly affected by ISE and Mix or OSe treatments, 
respectively. In contrast, OSe supplementation solely affected the expression of 22 
genes and commonly the expression 4 and 7 genes with ISe and Mix, respectively. 
For the Mix treatment, 33 genes were solely affected, but another 22 and 7 were 
commonly expressed with ISE and OSe, respectively. In addition, 11 genes were 
affected commonly by all three Se supplementation treatments relative to Control, 
whereas the expression of another 8 genes were differentially expressed among ISe, 
Mix, and OSe treatments, but did not differ from Control expression levels.  
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Bioinformatic Analysis of Se Treatment-specific Profiles  
In total, 69 (ISe), 73 (Mix), and 44 (OSe) DEG were solely or commonly 
affected by Se supplementation treatments.  The annotated genes within a Se 
treatment were subjected to bioinformatic analysis to gain insight into differences in 
the physiological capacities that might result from the separate Se treatments.  
Network analysis revealed several common and solely-affected networks.  The 
common network identified for ISe (ACIN1, GCG, GCLC, GHRH, ITGA2, Mir-222, 
MMP9, NPY1R, PDX1) and Mix (ACIN1, CCNB2, CDH4, CXCL2, FCGR2A, 
GCLC, ITGA2, MMP9) DEG was cellular movement.  The common network 
identified for OSe (CNGA1, GCLC, ITGA2, LDHB, LRRTM2, PLCZ1, OPTC, RIN2, 
RUFY3, SEPW1, TRPC5, VAMP5, ZNF238) and Mix (EIF4A1, FCGR2A, LALBA, 
PLCZ1, OPCT, SEPW1, SHD, TNFAIP8L2, TRPC5, TULP3) was cell-to-cell 
signaling and interaction.  
No networks were identified solely for OSe treatment.  In contrast, the solely 
identified networks for ISe were cellular growth and proliferation, DNA replication, 
recombination, and repair, cellular movement (CAPRIN2, CEND1, CNGA1, 
LRRTM2, NTM, SEPW1, SHD, THOC5, ZNF703) and organ development, 
carbohydrate metabolism, tissue development (CDH4, CEP350, GCM1, LALBA, 
Mir-222, OPCT, SNAPIN, TRPC5, THG1L).  For the Mix treatment, solely identified 
networks were cardiac proliferation, cardiovascular system development and function, 
cellular growth and proliferation (CEP350, CNGA1, FRAS1, GOLGA3, HBE1, IRX4, 
LEPRE1, MTMR2, PSME4, SNAPIN).  
Hierarchical Clustering of GeneChips into Se Treatment-specific Groups 
Hierarchical cluster analysis of the 139 DEG (Figure 4) revealed four distinct 
GeneChip clusters (9 GeneChips each) that were segregated by Se treatment and that 
were consistent with the PCA results. Specfically, OSe treatment GeneChips were 
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more closely aligned with Control GeneChips than were Mix GeneChips, and the ISe 
cluster was similar to Mix GeneChips and most dis-similar to Control GeneChips.  
Bioinformatic Analysis of Clustered DEG  
Hierarchical clustering of the 139 DEG also identified 8 patterns of gene 
expression that were sensitive to Se-treatment (Figure 4).To identify potential 
metabolic relationships among DEG within a cluster in Table 1, bioinformatics 
analysis was conducted on annotated DEG within a cluster. The predominant (the 
highest ratio of DEG to all molecules) networks were identified: Cluster 1, organismal 
disease (SEPW1) and molecular and mineral transport (TRPC5); Cluster 2, cell to cell 
signaling and interaction (PCDHB14, RUFY3); Cluster 3, tissue development and 
protein synthesis (CCNB2, CXCL2, DDHD1, GCG, MTMR2, PSME4, SNHG3-
RCC1, RIN2); Cluster 4, cell cycle (GSG2) and tissue development (QPCT, MFI2); 
Cluster 5, cell movement development (CDH4, CEND1, CNGA1, ITGA2, LALBA, 
MMP9, NTM, PCDHA2, SHD, ABO) and interaction (FGF22); Cluster 6, regulation 
of hormone (GHRH, Mir-222, PDX1) and skeletal disorders (FBXL13); Cluster 7, 
cellular function (LDHB, LRRTM2, PLCZ2, TNFAIP8L2, VAMP5, FRAS1) and 
developmental disorder (FRAS1); Cluster 8, cell signaling, molecular and mineral 
transport, and metabolism (ACIN1, FCGR2A, GOLGA3, LEPRE1, NPY1R, 
SNAPIN, SRP72, ZNF236, THG1L, THOC5) cell growth and tissue function 
(THG1L, ZNF22) DNA replication repair (ANDP2). 
Differentially Expressed MicroRNA (MiRNA) 
Six hundred twenty-one miRNA are detectable by the bovine GeneChip used 
for this study. Of these, 621 were expressed, but only three MiRNA (MiR-222, Mir-
2393, Mir-2300b) were identified among the 139 DEG (Table 1). Among the 
remaining annotated DEG, 1 putative mRNA target was identified for Mir-222, 20 for 
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Mir-2393, and 9 for Mir-2300b (Table 2). Among these mRNA targets, DDHD1 is 
common to both Mir-222 and Mir-2393, whereas RUFY3, LRRTM2, FRAS1 are 
common targets of both Mir-2393 and Mir-2300b.  
Bioinformatics analysis of the mRNA targets of each differentially expressed 
MiR was conducted to identify potential physiological consequences of Se treatment 
alteration of MiR expression (Table 2). Whereas MiR-222 is predicted to affect only 
one network, the 17 of the 20 differentially-expressed targets of MiR-2393 are 
associated with 6 networks, the most prominent (9 mRNA) being Cell Cycle, Cancer, 
and Neurological Disease. For MiR2300b, 7 of 9 putative target mRNA are identified 
with 4 networks, the most prominent (4 mRNA) being Cell Cycle, Cellular Assembly 
and Organization, DNA Repair Replication, Recombination, and Repair.  
DISCUSSION 
Experimental Model 
Little is known regarding the relationship between Se concentrations in the 
liver and liver gene expression, especially in cattle. The effect of Se supplementation 
on liver gene expression using a Se-deficient versus Se-supplemented experimental 
model in rats (Fischer et al., 2001) and chicks (Huang et al., 2011; Sun et al., 2011) 
have been reported. However, because most cow-calf operations in regions of Se-poor 
soils provide enough Se in diets to avoid Se deficiency. the goal of this research was 
to determine the effects of three Se supplementation strategies (ISe, Mix, OSe) on 
liver gene expression profiles using a Se-adequate experimental model.  
Descriptions of the experimental model, diets, and liver tissue collection, and 
Se content in the liver samples used for this trial have been published (Brennan et al., 
2011). However, briefly, liver Se content (μg/g) for Control (0.08 mg Se/day) group 
was essentially stable throughout the trial, whereas the Se concentration in ISe, OSe, 
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and Mix heifers increased to about 56 to 112 days and then were stable for the 
remainder of the trial (Figure 5, Brennan etal., 2011). The total daily Se consumption 
by individual heifers of the Control, ISe, Mix, and OSe treatment groups was 0.82, 
3.80, 3.69, and 3.76 mg/day, respectively. The liver Se concentration (µg/g) of these 
heifers at day 168 were 0.24 (Control), 0.40 (ISe), 0.49 (Mix), and 0.49 (OSe) and 
differed (OSe = Mix > ISE > Control) (Brennan et al., 2011). For the Control, ISe, 
and OSe treatments, these Se concentrations levels are consistent with those found in 
the previous pilot trial (Liao et al., 2010), which had liver Se concentrations (μg/g) of 
0.26, 0.34, and 0.47, respectively, from maturing Angus-cross heifers consuming 0.48, 
3.48, and 3.48 mg Se/day for 105 – 106 days (Liao et al., 2010). Importantly, Se 
concentrations of 0.25 to 0.50 µg/g in liver tissue are considered normal (Ullrey, 1987; 
Corah, 1996; Surei, 2006). Thus, the animal model used for both the present (and pilot) 
trial is robust with respect to both Se-adequatecy and Se form-dependent Se 
assimilation by liver tissue.  
Se Assimilation Levels and Gene Expression Profiles 
As just described, Se treatments affected liver Se assimilation by heifers. 
Microarray analysis was used to determine the effect of Se treatment on gene 
expression (relative mRNA and miRNA levels) and, by extension, Se treatment-
induced differences in physiological capacities. Microarray analysis revealed clear 
differences in the hepatic gene expression profiles of the four Se treatment groups 
(Figure 4). However, inter-treatment differences in Se content did not match 
differences in gene expression profiles. That is, although ISe-induced hepatic Se 
concentrations were more similar to Control concentrations, ISe-induced hepatic gene 
expression profiles were most different from Control profiles. Likewise, although the 
hepatic content of Se in Mix and OSe treatments were essentially identical, OSe 
46 
 
expression profiles were more similar to Control, and Mix to ISE (Figure 4). Thus, 
absolute hepatic Se assimilation was not a good indicator of gene expression. Instead, 
the form of Se consumed may be a better indicator. That is, the pattern of hepatic 
DEG was most similar between the treatments with the greatest proportion of organic 
Se (Control, lowest hepatic Se content) and OSe (one of the highest Se content), while 
the hepatic DEG expression profiles were similar between those animals consuming 
proportionately increasing amounts of inorganic sources of Se (Mix and ISe). 
Therefore, it appears that the form of Se consumed may be more important than the 
amount of Se assimilated. Based on this conclusion, future trials should assess the 
relationship between total Se assimilation, the form of Se assimilated, and patterns of 
gene expression.  
Common and Differential Selenium Form-Induced Metabolic Pathways 
Because the metabolic fates and pathways for OSe (SeCys, SeMet) and ISe 
(selenite) have distinctive, as well as common, components (Figure 6), an unexpected 
finding of this study was that the expression of only a few of the genes endcoding 
proteins responsible for Se-specific metabolism were altered. Athough expression of 
mRNA for 16 of 20 of Figure 6 proteins were detected by the GeneChips (data not 
shown), none of these were altered by Se-supplemental treatment. Assuming that Se 
might be limiting in non-supplemental heifers, these findings are somewhat 
unexpected given that supplementation of organic Se should result in proportionately 
greater amounts of SeCys to incorporate into the “regulated” selenoprotein synthesis 
pathway (tRNASec-mediated incorporation of SeCys into “selenoprotein” polypeptide 
chains), the “unregulated” pathway (non-specific competition between Met and 
SeMet binding by tRNAMet and incorporation into “Se-containing proteins”), and the 
trans-selenation pathway (Figure 6, Suzuki, 2005). In contrast, with the exception of 
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minor amounts of organic Se compounds contained in Se-assimilating ruminant 
microbes, inorganic dietary Se will not be metabolized through the the regulated 
pathway and its associated recycling capacity. However, the findings from this study 
indicate that the non-supplemental Control treatment expressed adequate amounts of 
these proteins and, thus, supports the understanding that our animal model (slow-
growing, maturing beef heifer) is one of Se adequency, not deficiency. 
Twenty-three of the 25 known mammalian selenoproteins (all but SEP15 and 
SEPN) were assayed by the microarray. Of these, only expression of SEPW1 was 
altered (Table 1). These results indicate that precursors and enzymes responsible for 
SeCys formation and incorporation into polypeptide chains were not lacking in non-
supplemented Control heifers. The upregulation of SEPW1 mRNA expression is 
consistent with this genes’ known sensitivity to supplemental Se. In this regard, the 
upregulation of SEPW1 mRNA indicates that the model was capable of responding to 
dietary Se supplementation.  
Functional Analysis of Heiarchial Clusters 
The hierarchical clustering of 139 DEG identified 8 patterns of gene 
expression that were sensitive to supplemental Se-treatment (Figure 4). Functional 
analysis was performed on the annotated DEG within each cluster to gain insight into 
the potential physiological significance of these responses. Eight transcripts from 
Cluster 1 are involved in cation transport and antioxidative activity. SEPW1 
(selenoprotein W-1) contains SeCys, encoded by the UGA codon. SEPW1 belongs to 
the selenoprotein W subfamily, of the selenoprotein WTH family, and functions as an 
antioxidant enzyme. Specifically, SEPW1 binds to glutathione which targets reactive 
oxygen species such as hydrogen peroxide, superoxide anion radical, and hydroxyl 
radical, which are toxic by-products of cellular oxygen metabolism (Jeong et al., 
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2002). The binding sites are thought to be SeCys
13
 and Cys
37
 residues (Jeong et al., 
2002). Homologues of transient receptor potential (TRP) genes encode a variety of 
cation channels, most of which conduct Ca
2+
 across the plasma membrane (Mori et al., 
2011).  
Transient receptor potential (TRP) channels play pivotal roles in sensing and 
adapting to a wide variety of environmental changes (Yamamoto et al., 2010). 
Immunolocalization studies have revealed that TRPC5 is distributed on both the 
apical and basal membrane in the endothelial cell layer of vascular tissue. TRPC5 
channels are activated by nitric oxide and inflammatory mediators via oxidative (S-
nitrosylation) modification of cysteine residues, which triggers the Ca
2+
 influx and 
other adaptation reactions after sensing the oxidative stress. This study found that the 
TRPC5 expression is equally stimulated by all forms of Se supplement. Thus, if 
mRNA levels represent functional capacity, then Se supplementation induced an 
increased capacity to respond to oxidative stress in Se-supplemented heifers versus 
the Se-adequate, but non-supplemented Control heifers.   
The cell-to-cell signaling was one pathway that indentified in Cluster 2 DEG. 
PCDHB14 expression was increased 1.28- to 1.35-fold by ISe and Mix treatments, 
respectively. In contrast, CYP2D14 and RUY3 expression were decreased by OSe. 
PCDHB14 is a cadherin protein that belongs to the protocadherin family. As such, 
PCDHB14 likely is involved in the modulation of synaptic transmission and the 
generation of specific synaptic connections (Frank and Kemler 2002). The up-
regulation of PCDHB14 by Mix and OSe Se treatments indicates a more active 
synaptic signal transmission.  
Cluster 3 DEG are involved in tissue development and protein synthesis. The 
Mix treatment up-regulated 13 of 15 genes in this cluster, whereas ISE downregulated 
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the gene for glucagon (GCG) and OSe downregulated RIN2. DDHD1 can generate 
the arachidonic acid-containing lysophosphatidylinositol that increases both the 
phosphorylation of the extracellular signal-regulated kinase (ERK) and intracellular 
Ca
2+
 levels (Yamashita et al., 2010). SNHG3-RCC1 is the regulator of chromatin 
condensation 1 that was the guanine nucleotide-exchange factor for the Ran GRPase, 
and functions as the nucleo-cytoplasmic transport, mitosis, and nuclear-envelop 
assembly. RCC1 has a propeller-like structure, one side binds to Ran, and the other 
side binds chromatin. Upon some post-translation modification, SNHG3- RCC1 can 
generate the RanGTP that is required for spindle assembly and chromosome 
segregation during the mitosis (Kline-Smith and Walczak, 2004).  
The pattern for Cluster 4 DEG senstivitiy to Se treatments was down-
regulation (-1.16- to -1.65-fold), with the exception of MF12, which was upregulated 
(1.07-fold) by ISe treatment. GSG2 was down-regulated 1.23-fold by OSe treatment. 
GSG2 is involved in the chromatin modification especially the histone 
phosphorylation, which provides a chromatin binding site for chromosomal passenger 
complex at centromeres to regulate chromosome segregation during the mitosis 
(Wang et al., 2011). ZNF238 (Zinc Finger 238; RP58) also is a DNA binding protein 
and acts to repress transcription, likely by binding the Dnmt3a DNA 
methyltransferase. ZNF238 is a member of the POZ-zinc finger family (Okado et al., 
2009), which are important regulators of DNA damage responses, cell-cycle 
progression, and many developmental events (Kelly and Daniel, 2006).Of the Cluster 
4 DEG, MiR2393 was the most affected, being significantly downregulated 1.41- to 
1.65-fold by Mix and OSE, and quantitatively down-regulated by ISe, respectively. 
As with ZNF238, Mir2393 acts to repress expression but by binding mRNA rather 
than DNA (see below).   
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Similar to MiR2392, QPCT (glutaminyl-peptide cyclotransferease or 
glutaminyl cyclase) mRNA expression also was affected by all 3 Se treatments, being 
downregulated by 1.16-, 1.26-, and 1.30-fold by ISe, Mix, and OSe, respectively. 
QPCT is involved in the synthesis of pyroglutamyl peptides by posttranslational 
cleavage of nascent gene products to their respective N-terminal pyroglutamyl 
bioactive peptides, including thyroid-releasing hormone, gonadotrphophin-releasing 
hormone, and corticotrophin-releasing hormone (Fischer and Spiess, 1987). However, 
paradoxically, QPCT mRNA was not detected by a previous Northern blot analysis 
(Pohl et al., 1991), although strong expression in pituitary and most brain regions, and 
relatively, lesser expression by retina, kidney, thymus, and skeletal muscle. Thus, 
either our microarray detection of bovine QPTC mRNA expression by hepatoctytes 
was more sensitive then Northern blot analysis, or differences in liver tissue samples 
assayed existed (slaughterhouse tissue versus animals of known origin). If our liver 
expression of QPTC is validated, then an important finding from this study is that Se 
supplementation may alter QPTC-mediated metabolism, most auspiciously (perhaps) 
that occurring in the pituitary.  
Cluster 5 DEG genes were up-regulated by any form of supplemental Se 
relative to Control. The predominant network of Cluster 5 was cell movement 
development. CDH4 is a calcium-dependent cell-cell adhesion glycoprotein, that is 
comprised of cadherin repeats and that is important for tissue development. The 
CNGA1 encoded protein in plasma membrane increases translocation of Ca
2+ 
and Na
+
 
in extracellular space to Ca
2+
 in cytoplasm (Kaupp and Seifert, 2002). THOC5 78 kd 
FMIP protein decreases differentiation of macrophages (Tamura et al., 1999) and it is 
involved in the differentiation of monocytes (Carney et al., 2009) and can increase the 
differentiation of granulocytes.  
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ITGA2 encodes the alpha-chain of integrins found in T cells, fibroblasts, and 
is involved with cell adhesion and cell-surface mediated signaling. Importantly, the 
integrin complex can mediate the activation of hepatic stellate cells (Friedman, 2000). 
ITGA2 upregulation indicates greater capacity for healing and IL-3 mediated immune 
respose. ITGA2 also is involved in activation of monocyte upon to trigger monocyte 
migration to inflammatory sites to regulate IL-13-mediated monocyte activation 
(Yakubenko et al., 2011). The expression of ITGA2 mRNA was upregulated equally 
(1.22- to 1.34-fold) by all 3 Se treatments. The upregulation of it for Se treatment 
indicates better tissue wound healing capacity in response to injury, and also indicates 
an increased activation of macrophages. 
Although not identified as part of the cell movement development network by 
IPA analysis, GJB4 is a transmembrane connexin protein that forms gap junctions. 
Gap junctions provide for a unique system of intercellular communication allowing 
rapid transport of small molecules from cell to cell (Cancelas et al., 2000). GJB4 is 
expressed by the liver cobblestone area-forming cells and is responsible for the 
communication and supportive ability and GJB4-dependent gap junction can 
contribute to the regulation of the clonal outgrowth of hematopoietic progenitors 
(Cancelas et al., 2000). It also reported that GJB4 deficiency impairs hemopoiesis and 
the GJB4 knockout fetuses have a lower content of progenitor and stem cells in their 
liver as compared with their wt littermates. Besides, the GJB4 may participate in the 
function of B and T lymphocytes and macrophages thus influence the body immune 
function (Alves et al., 1996; Alves et al., 1998). GJB4 mRNA expression was 
upregulated 1.13- and 1.26-fold by ISe and Mix treatments, respectively, and tended 
to be upregulated (1.10-fold) by OSe treatment. This upregulation suggests that 
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heifers consuming inorganic and mixed forms of Se had greater capacities for hepatic 
GJB4-mediated cell-to-cell communication and immune system function. 
SLC6A17 is a glutamatergic- and GABA- (somewhat) specific neuron 
transporter responsible for Na
+
-dependent absorption of (primarily) glutamine and 
proline from the cytosol into synaptic vesicles (Zaia and Reimer, 2009). In liver tissue, 
SLC6A17 was equally upregulated by ISe and Mix. If the bovine expression pattern 
for SLC6A17 is the same for other species, then this finding indicates the the 
glutamatergic neurons which innervate the liver have an increased neural propagation 
function, due to the increased capacity to absorb the precursor for glutamate, 
glutamine.  
For Cluster 6 DEG, ISe treatment increased gene expression for 8 of 11 
annotated DEG, whereas Mix decreased expression of 3 genes and OSe had no effect. 
The predominant network found for Cluster 6 genes was regulation of hormone 
metabolism (GHRH, PDX1). GHRH is known to stimulate NF-kappa beta 
transcription factor that activates angiogenic factor and expression of genes involved 
in encoding enzymes in the prostaglandin-synthesis pathway (NCBI, 
http://www.ncbi.nlm.nih.gov). The transcriptional factor pancreatic duodenal 
homeobox 1 (PDX1) plays a pivotal role in pancreatic beta-cell differentiation, and 
insulin gene expression and synthesis (German et al., 1995; Offield et al., 1996; 
Ahlgren et al., 1998; Bernal-Mizrachi, et al., 2001). We found PDX1 mRNA was 
upregulated 1.17-fold by ISe but not affected by Mix or OSE treatments. Although it 
has been demonstrated that PDX expression can be increased through 
hyperacetylation of H3 and H4 histones of the Pdx1 promoter in response to 
overexpression of Se-dependent cellular glutathione peroxidase-1 (GPX1) (Wang et 
al., 2008), GPX1 expression was not affected by Se treatment (data not shown). 
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Therefore, whether PDX1 expression was induced directly by increased inorganic 
concentrations due to ISe treatment effects, indirectly through post-transcriptional 
effects on GPX1, or by a different mechanism, remains to be determined.  
 Of the 10 DEG in Cluster 7, 2 (LDHB, VAMP5), were upregulated by OSe 
treatment whearas 6 were down regulated by ISe treatment, 1 by ISe or Mix, and 1 by 
Mix alone. Genes in Cluster 7 are involved in the membrane adhesion (FRAS1), 
immune function (TNFAIP8L2), and glycolysis (LDHB) networks.  
The effect of Se treatment on Cluster 8 genes was similar to that of Cluster 7 
genes; OSe increased expression of 5 of 20 genes in Cluste 8, whereas ISe (5), ISe 
and Mix (6), or Mix alone (4) decreased expression of DEG. These DEG are involved 
in cell signaling, molecular and mineral transport, and tissue growth and function.  
Cluster 8 also contained two of the most strongly affected DEG in the trial. 
Bos taurus major histocompatibility complex, class II, DQ alpha 2 (BOLA-DQA2; 
Morooka et al., 1995) BOLA-DQA2 mRNA expression was increased 2.67-fold by 
OSe, but was not affected by ISe or Mix treatments. This finding suggests that OSe-
consuming animals may have a greater capacity to respond to pathogen challenges 
(Handunnetthi et al., 2009; Hou et al., 2012) assuming that OSe heifers were not 
stimulated by a pathogen challenge not present to the other treatment groups. The 
additional understanding that Control (0.08 mg Se/day from diet) and Mix (diet plus 
1.5 mg supplemental OSe) treatments failed to stimulate BOLA-DQA expression 
suggests that a threshold amount of supplemental OSe is required that exceeds 1.58 
mg of organic Se/day in organic forms.  
In contrast to BOLA-DQA2, expression of CEP350 (centromere protein 
350kDa) was decreased 1.5- and 1.39-fold by ISe and Mix, respectively. CPE350 
(Zimin et al., 2009) is localized to the centrosome and thought to be involved with the 
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regulation of nuclear hormone receptor function. However, the physiological 
relevance of decreased CEP 350 expression is not obvious.    
Neuropeptide Y is one of the most abundant neuropeptides in the mammalian 
nervous system and exhibits effects on psychomotor activity, food intake, regulation 
of central endocrine secretion, and potent vasoactive effects. NPY is found in the liver 
and can regulate blood flow in, and secretion by, the liver (Ding et al., 1991; El-Salhy, 
2000). The receptor for NPY (NPY1R) is expressed by the liver and is associated with 
glycoprotein processes. Hepatic production of the glycoprotein hormone, which 
regulates production of bone marrow platelets (http://review-
center.net/metabolism/liver-metabolism- pathways-and-its-disorders/) and several 
other glycoproteins, is expressed in fibrotic livers (Li and Friedman, 1999; Tsukada et 
al., 2006). Aspartate aminotransferase and alanine aminotransferase are hepatic 
biomarkers associated with NPY1R copy number variation (Kim et al., 2010). That 
NPY1R was downregulated (1.32-fold) by ISe, but unaffected by Mix or OSE 
treatments, suggests a decreased regulation of glycoproteins and glycoprotein 
hormone in liver tissue of ISe heifers.  
The SANPIN is a SNAP-associated protein, and a component of the SNARE 
complex of proteins that is required for synaptic vesicle docking and fusion (Ilardi et 
al., 1999). SNAPIN is involved with synaptic vesicle maturation (Pan et al., 2009) and 
induces synaptic transmission after binding of synaptic vesicles (Ilardi et al., 1999). 
SNAPIN expression was down-regulated by ISe (1.14-fold) and Mix (1.19-fold), but 
not by OSe. Thus, ostensibly, heifers consuming ISe or Mix forms of Se would have 
impaired synaptic transmission capacity relative to Control and OSe heifers, animals 
consuming only organic forms of Se. 
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Relationship between DEG and MiRNA expression 
The expression of 621 miRNA was detected by miRNA analysis (data not 
shown). Of these, the expression of three (MiR222, MiR2393, MiR2300b) were 
affected by Se supplementation treatment. Whereas the expression of MiR222 has 
been reported in other species, but the expression of MiR2393 and Mir2300b is 
unique to bovines.  
MiR222 (Cluster 6) was up-regulated (1.23-fold) by ISe treatment, but not by 
the other treatments. Because upregulation of MiR are associated with decreased gene 
expression, this result suggests that ISe treatment has a negative effect on genes 
controlled by MiR222. Of the 85 annotated DEG, only seven (GCG, glucagon from 
Cluster 3; NPY1R, TMEM168, THG1L, THOC5, ADNP2, from Cluster 8) shared 
this pattern of ISe-induced decreased expression (Table 1). However, none of these 
are putative targets of MiR222. Instead, only DDHD1 is a putative target (Table 2). 
However, DDHD1 expression was up-regulated 1.30 fold by Mix treatment (Table 1). 
Thus, (a) DDHD1 was not a target of MiR222 and (b) the consequence of MiR22 
upregulation by Mix Se treatment is not obvious.  
In contrast to MiR222, MiR2393 expression was decreased by Se treatment, 
thus its inhibitory effect of target mRNA would be to increase their expression. 
Specifically, MIR 2393 (Cluster 4) expression tended to be downregulated (1.20-fold) 
by ISe and was downregulated by Mix (1.41-fold) and OSe (1.65-fold) (Table 1). 
However, of the 17 putative targets of MiR2393 (Table 2), one of these, QPCT, was 
in the same cluster (Cluster 4, any form of Se supplement down regulated DEG as 
MiR2393 (Table 1). Therefore, QPCT does not appear to be a target of MiR2393.  
As for MiR222, DDHD1 also is a target of MiR2393. Unlike MiR222, 
MiR2393 was downregulated by Mix treatment concomitant with an upregulation of 
DDHD1. Thus, the data are consistent with DDHD1 expression being regulated by 
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Mix treatment downregulation of MiR2393, as opposed to regulation by MiR222. 
DDHD1 can generate the arachidonic acid-containing lysophosphatidylinositol that 
increases both the phosphorylation of the extracellular signal-regulated kinase (ERK) 
and intracellular Ca
2+
 levels (Yamashita et al., 2010). TRP5C also is a putative target 
of MiR2393 whose expression was upregulated by ISe (1.37-fold), Mix (1.58-fold), 
and OSe (1.67-fold). As noted before, TRP5C (Cluster 1) expression increases the 
capacity for Ca
2+
 influx into cells (Mori et al., 2011). Together, the concomitant 
downregulation of MiR2393 and upregulation of DDHD1 and TRP5C by at least Mix 
and OSe supplementation suggests one mechanism by which Se supplementation of 
Se-adequate diets results in increased redox potential (Yamamoto et al., 2010). This 
supposition is strengthened by the observation that SEPW1 (Cluster 1), which 
functions as an antioxidant enzyme (Jeong et al., 2002), also is upregulated by all 
three Se supplements (Table 1).  
As for MiR2300b, the effect of Se supplementation on liver expression of 
MiR2300b was to decrease it (Table 1). Thus, the expression of MiR2300b targets 
should be increased. Unlike MiR2393, however, MiR2300b was down-regulated by 
ISe (1.25-fold) and Mix (1.37-fold) treatment, not OSe and Mix. Of the putative seven 
DEG MiR2300b targets (Table 2), four (FRASI, RUFY3, SNAPIN, THG1L) were 
downregulated by Se treatment and thus not likely regulated by MiR2300b expression. 
Of the remaining three putative targets, LRRTM2 is upregulated by ISe and OSe, 
SNHG3-RCC1 is upregulated by Mix, and SEPW1 is upregulated by all three Se 
supplement forms. Thus, the expression patterns of none of DEG that are putative 
targets of MiR2300b match those of MiR2300b, as would be expected in their 
expression was regulated by MiR2300b. 
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Predominant Se Treatment-specific Effects on Gene Expression 
Although heiarchial clustering of the 139 DEG resulted in the identification of 
eight different gene expression clusters, consideration of the Se treatment effects on 
only the 85 annotated DEG (Table 1) reveal four prominent, Se form-induced 
expression patterns. First, from Clusters 1 (3 genes) and 5 (15 genes), any Se form 
supplement (ISe, Mix, OSe) increased gene expression relative to Control. Second, in 
Cluster 3 (15 genes), it is apparent that the Mix treatment upregulates gene expression, 
whereas OSe or ISe downregulates gene expression. Third, from Cluster 6 (11 genes), 
whereas OSe does not affect expression, ISe treatment upregulates gene expression 
and Mix treatment downregulates expression. Fourth, from Clusters 7 (10 genes) and 
8 (20 genes) either Mix or ISe treatments downregulate gene expression whereas OSe 
upregulates expression.  
In addition, two other Se form-induced patterns are represented in the gene 
clusters, but the relative few genes involved with each cluster reduce confidence in 
their validity. Specifically, from Cluster 2 (3 genes) it would appear that whereas OSe 
upregulates gene expression, ISe or Mix decreased expression. In contrast, from 
Cluster 4 (5 genes), whereas one gene is downregulated by all three Se treatments, 
three others are downregulated by OSe or Mix, but another is upregulated by only ISe 
treatment.  
Comparison of Current to Previous Studies on the Effect of Dietary Se form on 
Hepatic Gene Expression in Developing Beef Heifers.  
Previously, we found that dietary supplementation of none or 3 mg Se/day as 
ISe or OSe to maturing beef heifers (Liao et al., 2010) altered the expression of about 
80 mRNA. Of these, only one DEG (LEPRE1, leucine proline-enriched proteoglycan 
(leprecan) 1) was found altered by Se supplementation (ISe, OSe) in both experiments. 
However, in the Liao et al. (2010) trial, LEPRE1 was upregulated by ISe (1.53-fold) 
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and OSe (1.47-fold) treatments (Mix treatment was not tested), whereas in the present 
trial, LEPRE1 was not affected by ISe or OSe treatment but was downrregulated 
(1.15-fold) by Mix treatment (which was not used in the Liao et al. (2010) trial).  
At first glance, it seems surprising that more similarities were not found 
between the two studies given that the same experimental model was used. However, 
upon further consideration, the lack of similaritiy between gene expression induced by 
ISe and OSe treatments in the pilot (liao et al., 2010) versus current trial may be 
reasonable given the following differences: (1) although similar in magnitude, Se 
concentrations in liver after 105/106 days of supplementation (Liao et al., 2010) may 
not have been stable, as they were after 168 days (current trial), (2) different 
experimental designs were used (non-supplemented Control, ISe, and OSe and n 
=6/treatment for Liao et al., 2010 versus non-supplemented Control, ISe, OSe, and 
Mix, n = 9/treatment for the present study), (3) differences in the microarray assays to 
detect gene expression due to the use of different GeneChips, and (4) a combination 
of the above. With regard to the third possibility, Liao et al. (2010) used the 
commercially-available Affymetrix GeneChip Bovine Genome Array, with its 24,016 
gene transcripts, and annotated using NetAffix annotation database for 3’ IVT 
Expression on Bovine GeneChip Array 3’-weighted coverage of transcripts 
(http://www.affymetrix.com/analysis/index:affx, Affymetrix, Inc.).  In contrast, the 
present trial used the custom WT Btau 4.0 Array (version 1), which contained 26,303 
gene transcripts, a complete 5’ to 3’ coverage of gene transcripts, and annotation 
based on an updated draft (4.0) of the Bovine Genome. Of note, the Btau 4.0 
GeneChip used in the current study contained 621 microRNA, whereas the 
Affymetrix GeneChip Bovine Genome Array contained none.  
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SUMMARY 
The expression pattern of these affected genes appeared to be more similar for 
Control and OSe than Control and ISe, and Mix is between OSe and ISe. This result 
would suggest that the different gene expression profile of OSe, Mix, ISe heifers, was 
not caused by an inter-form gradient (0, 50, 100% ISe or OSe) effect, but by their 
biochemical form and form-specific metabolic pathways.  
The affected genes were grouped into eight distinct clusters. Functional 
analysis of these affected genes by cluster showed that they are associated with 
different physiological functions, including (1) nutrient metabolism, (2) molecular 
and mineral transport, (3) cell signaling and interaction, (4) cellular growth, 
proliferation, (5) immune response and hormone regulation, and (6) tissue/organ 
development and function.  This result would gain a more complete perspective of 
how different dietary forms of Se caused the specific hepatic transcripts expression 
and biofunctions profile changed.  Regarding the effect of the supplemental Se forms, 
eight distinct groups of genes were identified: those (1) commonly affected by ISe 
and OSe supplementation, (2) commonly affected by ISe and Mix supplementation, (3) 
commonly affected by OSe and Mix supplementation, (4) commonly affected by ISe, 
OSe, and Mix supplementation, (5) solely affected by ISe supplementation, (6) solely 
affected by OSe supplementation, (7) solely affected by Mix supplementation, (8) 
affected by ISe, Mix, or OSe supplementation but not differ from Control.  
In addition, the result of the miRNA analysis indicates the possible 
relationship of the changed hepatic gene expression and biofunctions with the 
differentially up- or down- regulation of microRNAs caused by different Se 
supplementation. The true nature of these relationships would still require more 
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research to fully understand exactly how these microRNAs affect their targets 
expression.   
CONCLUSION 
The objectives of the current work were to (1) compare hepatic gene 
transcriptome profiles when hepatic liver assimilation was stable (d 168) using 
microarray methods, and (2) conduct bioinformatics analysis of these profiles to 
predict altered hepatic physiological capacities induced by specific forms of Se 
supplement. 
Hepatic gene transcriptome profiles were successfully compared, resulting in 
the understanding that the chemical form (inorganic, organic, mix) of supplemental Se 
differentially affected hepatic gene expression of growing heifers after 168d 
supplementation.  The bioinformatics analysis results indicated that Se treatments 
induced differentially expressed hepatic genes could be grouped into several clusters 
upon their expression pattern, and the genes in each cluster are indicative of 
differentially changed biofunctions.  In addition, the putative target mRNAs of Se 
treatment induced differentially expressed miRNA could influence different 
biofunctions, but more work needs to be done to validate these findings. 
  
Table 1. Hepatic gene transcripts affected by dietary selenium (Se) supplementation treatment for 168 days to growing beef 
heifers transcripts 
  
 Dietary Se treatments
2
 
  
Transcript ID Gene Symbol
3
 Gene Description  Control ISe Mix OSe  SEM
4
 P-value
5
 
Cluster 1         
12907339 TRPC5 transient receptor potential cation channel, subfamily C, 
member 5 
1.00000
a
 1.36791
b
 1.58006
b
 1.66591
b
 0.12907  0.002725  
12697969 LOC100139773 hypothetical LOC100139773 1.00000
a
 1.15171
a,b
 1.36042
b
 1.27082
b
 0.08467  0.006423  
12697805 LOC786881 similar to hCG1812167 1.00000
a
 -1.03848
a
 1.05093
a
 1.24424
b
 0.07294  0.006400  
12675620 ---Intron --- 1.00000
a,b
 -1.28400
b
 1.39857
a
 1.44240
a
 0.18484  0.006020  
12914697 LOC100336032 PREDICTED: Bos taurus hypothetical protein 
LOC100336032 
1.00000
a
 1.15312
a,b
 1.13500
a
 1.33547
b
 0.07299  0.005211  
12752300 SEPW1 selenoprotein W, 1  1.00000
a
 1.22275
b
 1.21631
b
 1.26013
b
 0.05227  0.000289  
12710910 NEK5 NIMA (never in mitosis gene a)-related kinase 5 1.00000
a
 1.00664
a
 1.08321
a,b
 1.15446
b
 0.04425  0.007897  
12677772 ---Intron --- 1.00000
a
 1.11436
a
 1.22302
a
 1.60125
b
 0.12704  0.006116  
Cluster 2         
12914839 LOC100336100 PREDICTED: Bos taurus hypothetical protein 
LOC100336100 
1.00000
a
 1.15229
b
 1.18140
b
 1.03912
a
 0.04393  0.001174  
12881728 PCDHB14 protocadherin beta 14 1.00000
a
 1.28212
b
 1.34957
b
 1.06088
a
 0.09183  0.006410  
12864124 CYP2D14 cytochrome P450, family 2, subfamily D, polypeptide 6 1.00000
a,b
 1.15627
a
 1.09450
a
 -1.20399
b
 0.08664  0.007010  
12871032 RUFY3 RUN and FYVE domain containing 3 1.00000
a
 1.02846
a
 1.06498
a
 -1.16205
b
 0.05771  0.005646  
12764375 LOC532807 similar to RUN and FYVE domain containing 3  1.00000
a
 1.09947
a,b
 1.15836
b
 -1.09996
a
 0.06654  0.008889  
Cluster 3         
12847828 MGC134040 hypothetical protein MGC134040 1.00000
a
 -1.03393
a
 1.17224
b
 -1.06679
a
 0.06037  0.005824  
12869909 CXCL2 chemokine (C-X-C motif) ligand 2 1.00000
a
 -1.03514
a
 1.38450
b
 -1.13931
a
 0.11938  0.003537  
12693465 CCNB2 cyclin B2 1.00000
a
 -1.06124
a
 1.34891
b
 -1.16518
a
 0.11918  0.005328  
12774328 GCG glucagon 1.00000
a
 -1.09897
b
 1.04313
a
 -1.06086
a,b
 0.03330  0.001132  
12699461 PFN4 profilin family, member 4 1.00000
a
 1.20285
a,b
 1.33732
b
 -1.00647
a
 0.09570  0.007251  
12786583 IRX4 iroquois homeobox 4 1.00000
a
 1.03334
a
 1.17588
b
 -1.02677
a
 0.04733  0.002060  
12826590 LOC531024 similar to olfactory receptor 1200 1.00000
a
 1.06087
a
 1.21436
b
 1.07856
a
 0.03869  0.000243  
12686044 LOC537248 similar to ACPL2 protein 1.00000
a
 1.19225
b
 1.35993
b
 1.05331
a,b
 0.07236  0.000661  
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Table 1. (Continued) 
12687785 RNASE12 hypothetical protein LOC100297737  1.00000
a
 -1.01829
a
 1.42337
b
 -1.05685
a
 0.08304  0.000151  
12716554 RIN2 Ras and Rab interactor 2  1.00000
a
 -1.00644
a
 1.09313
a
 -1.15966
b
 0.05574  0.001630  
12782928 SNHG3-RCC1 SNHG3-RCC1 readthrough transcript 1.00000
a
 1.07997
a,b
 1.15455
b
 1.02993
a,b
 0.04166  0.009548  
12827960 PLAC9 placenta-specific 9  1.00000
a
 1.13081
a,b
 1.32674
b
 1.10323
a,b
 0.05955  0.000667  
12900046 LOC510904 hypothetical LOC510904 1.00000
a
 1.32197
b
 1.33335
b
 1.23397
b
 0.08776  0.006865  
12905415 LOC539973 similar to Zinc finger, DHHC-type containing 3 1.00000
a
 1.08064
a
 1.32775
b
 1.08349
a
 0.07614  0.007144  
12729265 MTMR2 myotubularin related protein 2  1.00000
a,b
 -1.02685
a
 1.09178
c
 1.03129
b
 0.02711  0.001488  
12706499 PSME4 proteasome (prosome, macropain) activator subunit 4 1.00000
a
 1.02009
a
 1.19114
b
 1.00366
a
 0.05130  0.003979  
12676376 ---Intron --- 1.00000
a
 1.01106
a
 1.30861
b
 1.32247
b
 0.10309  0.009497  
12803871 LOC782475 similar to olfactory receptor 1368 1.00000
a
 -1.13553
a
 1.36319
b
 1.09288
a,b
 0.11226  0.005933  
12910859 eIf4a1 eukaryotic translation initiation factor 4A1 1.00000
a
 1.00747
a
 1.21265
b
 1.10533
a,b
 0.05802  0.007803  
12814476 ANKRD61 ankyrin repeat domain 61  1.00000
a
 1.02440
a
 1.21770
b
 1.08275
a
 0.05766  0.007762  
12677234 ---Intron --- 1.00000
a
 1.26833
a
 1.71743
b
 1.12841
a
 0.14605  0.005896  
12693689 DDHD1 DDHD domain containing 1 1.00000
a
 1.04630
a
 1.29974
b
 1.02109
a
 0.06566  0.001069  
12675450 ---Intron --- 1.00000
a,c
 -1.43052
b
 1.21088
c
 -1.22692
a,b
 0.15143  0.008101  
Cluster 4         
12677448 ---Intron --- 1.00000
a
 1.13538
a
 -1.37222
b
 -1.39136
b
 0.13136  0.003895  
12676664 ---Intron --- 1.00000
a
 -1.28715
a,b
 -1.38955
b,c
 -1.80657
c
 0.15769  0.006690  
12765783 GSG2 germ cell associated 2 (haspin) 1.00000
a
 -1.02219
a
 -1.03877
a
 -1.23345
b
 0.06242  0.008242  
12888519 LOC788287 similar to Olfactory receptor 90  1.00000
a
 1.03204
a
 -1.04864
a
 -1.18675
b
 0.05684  0.005632  
12698464 QPCT glutaminyl-peptide cyclotransferase  1.00000
a
 -1.16423
b
 -1.26451
b
 -1.29939
b
 0.06257  0.001040  
12818810 MIR2393 microRNA mir-2393 1.00000
a
 -1.20463
a,b
 -1.41205
b,c
 -1.65305
c
 0.09321  0.000119  
12911831 ZNF238 Zinc finger 238 (RP58) 1.00000
a
 1.02814
a
 -1.10135
a,b
 -1.17690
b
 0.05856  0.008190  
12686393 MFI2 antigen p97 (melanoma associated) identified by 
monoclonal antigen 
1.00000
a,b
 1.07395
b
 -1.06797
a
 -1.10413
a
 0.04999  0.009302  
12676594 ---Intron --- 1.00000
a
 1.05904
a
 1.13670
a
 -1.26234
b
 0.09904  0.005182  
Cluster 5         
12796744 TTC21A tetratricopeptide repeat domain 21A 1.00000
a
 1.21548
b
 1.01361
a
 1.02297
a
 0.06029  0.007711  
12912929 CAPRIN2 caprin family member 2 1.00000
a
 1.13153
b
 -1.02243
a
 -1.05430
a
 0.04810  0.006433  
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Table 1. (Continued) 
12914495 LOC516089(discon) PREDICTED: Bos taurus olfactory receptor 78-like 1.00000
a
 1.25318
b
 1.15570
b
 1.12760
b
 0.05707  0.004526  
12879404 FGF22 fibroblast growth factor 22 1.00000
a
 1.29373
b
 1.08106
a
 1.08686
a
 0.07032  0.006865  
12873243 CNGA1 cyclic nucleotide gated channel alpha 1 1.00000
a
 1.19197
b
 1.13980
b
 1.12575
b
 0.04591  0.004660  
12857050 LALBA lactalbumin, alpha 1.00000
a
 1.23641
b
 1.20520
b
 1.02791
a
 0.06083  0.001969  
12705807 ABO ABO blood group (transferase A, alpha 1-3-N-
acetylgalactosaminy 
1.00000
a
 1.22678
b
 1.10102
a,b
 1.02565
a
 0.05988  0.007013  
12726472 LOC100300575 similar to olfactory receptor 154  1.00000
a
 1.25720
c
 1.20417
b,c
 1.08372
a,b
 0.05796  0.002456  
12807139 LOC786846 similar to olfactory receptor 108 1.00000
a
 1.18358
b
 1.14196
b,c
 1.02988
a,c
 0.05462  0.009475  
12882374 PCDHA2 protocadherin alpha 2 1.00000
a
 1.16689
b
 1.02240
a
 -1.00409
a
 0.04904  0.008942  
12911511 ADAM7 Disintegrin and metalloproteinase domain-containing 
protein 7-like 
1.00000
a
 1.29932
b
 1.16221
b
 1.16758
b
 0.05890  0.001454  
12834487 NTM neurotrimin  1.00000
a
 1.25025
b
 1.18765
b
 1.17953
b
 0.06262  0.007055  
12786958 ITGA2 integrin, alpha 2 (CD49B, alpha 2 subunit of VLA-2 
receptor)  
1.00000
a
 1.27304
b
 1.22285
b
 1.33601
b
 0.07739  0.004259  
12720027 CDH4 cadherin 4, type 1, R-cadherin (retinal)  1.00000
a
 1.19777
b
 1.22550
b
 1.10903
a,b
 0.06082  0.009903  
12691885 LOC614591 similar to Olfr736 protein  1.00000
a
 1.31777
b
 1.07387
a
 -1.01174
a
 0.07211  0.001495  
12747236 LOC531152 similar to solute carrier family 5 (sodium/glucose cotran 1.00000
a
 1.17262
b
 1.08239
a,b
 1.02624
a
 0.04312  0.004690  
12687141 LOC781919 hypothetical LOC781919 1.00000
a
 1.29038
b
 1.09990
a
 -1.02790
a
 0.07560  0.003120  
12831279 LRFN4 leucine rich repeat and fibronectin type III domain 
containin 
1.00000
a
 1.25464
b
 1.20157
b
 1.07978
b
 0.06154  0.003386  
12693387 LOC100337247 hCG1812119-like 1.00000
a
 1.33301
b
 1.22073
b
 -1.02350
a
 0.09509  0.005659  
12885640 SHD Src homology 2 domain containing transforming protein D 1.00000
a
 1.17028
b
 1.16044
b
 1.07479
a,b
 0.04725  0.006491  
12843025 SLC6A17 solute carrier family 6, member 17 1.00000
a
 1.26507
b
 1.23217
b
 1.11242
a,b
 0.06281  0.002701  
12906697 LOC100336642 hypothetical protein LOC100336642 1.00000
a
 1.19347
b
 1.23236
b
 1.07057
a,b
 0.05958  0.004127  
12707153 LYG2 lysozyme G-like 2 1.00000
a
 1.10830
a,b
 1.22910
b
 1.05533
a,b
 0.05476  0.004287  
12713813 MMP9 matrix metallopeptidase 9 (gelatinase B, 92kDa gelatinase, 
92k 
1.00000
a
 1.24610
b
 1.20563
b
 1.08945
a,b
 0.05874  0.002801  
12842299 GJB4 gap junction protein, beta 4, 30.3kDa 1.00000
a
 1.13385
b
 1.26389
b
 1.10493
a,b
 0.05783  0.003008  
12910332 LOC618023 similar to mCG1035526 1.00000
a
 1.13489
b
 1.16805
b
 1.00666
a
 0.05158  0.006880  
12829684 CEND1 cell cycle exit and neuronal differentiation 1 1.00000
a
 1.20278
b
 1.10631
a,b
 -1.04940
a
 0.05132  0.000338  
12911453 LOC617745 PREDICTED: Bos taurus histone cluster 1, H2bd-like 1.00000
a
 1.33297
b
 1.26593
b
 1.02369
a
 0.08867  0.004406  
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Table 1. (Continued) 
12677810 ---Intron --- 1.00000
a
 1.80027
b
 1.44397
a,b
 1.01137
a
 0.18686  0.007738  
Cluster 6         
12677714 ---Intron --- 1.00000
a
 1.25973
b
 1.04358
a
 1.23621
b
 0.07479  0.006589  
12802414 LOC523769 similar to Olfactory receptor 11A1 (Olfactory receptor OR 1.00000
a
 1.33145
b
 1.17429
b
 1.17281
b
 0.07550  0.008159  
12741683 LOC100295022 similar to pre-B lymphocyte gene 2 1.00000
a,c
 1.12993
a,b
 -1.06419
c
 1.17265
b
 0.06415  0.005043  
12740074 LOC530749 hypothetical LOC530749  1.00000
a
 1.18507
b
 -1.01920
a
 1.08987
a,b
 0.05729  0.008473  
12804717 GCM1 glial cells missing homolog 1 (Drosophila) 1.00000
a
 1.20950
b
 1.04205
a
 1.05058
a
 0.05491  0.009211  
12686542 C1H21ORF7 chromosome 21 open reading frame 7 ortholog  1.00000
a
 1.04049
a
 -1.16979
b
 -1.03255
a
 0.05544  0.006607  
12906283 MIR222 microRNA mir-222  1.00000
a
 1.22316
b
 -1.00025
a
 -1.09591
a
 0.06853  0.001913  
12824553 ZNF703 zinc finger protein 703 1.00000
a
 1.14629
b
 -1.04146
a
 1.03012
a
 0.04940  0.007012  
12730430 LOC788649 similar to odorant receptor HOR3beta3 1.00000
a
 1.22925
b
 -1.00493
a
 1.07249
a
 0.06580  0.008928  
12911627 LOC790172 PREDICTED: Bos taurus membrane glycoprotein gp140-
like 
1.00000
a
 1.25359
b
 1.10068
a,c
 1.15272
b,c
 0.05657  0.006471  
12713247 LOC100196900 hypothetical LOC100196900 1.00000
a
 1.09330
a
 -1.00273
a
 -1.18405
b
 0.07243  0.008923  
12866241 TULP3 tubby like protein 3 1.00000
a
 1.06038
a
 -1.11448
b
 -1.00561
a
 0.04430  0.007012  
12876076 LOC782977 similar to pol protein 1.00000
a
 1.16389
b
 -1.10204
a
 1.06022
a,b
 0.06658  0.008782  
12913095 PAKD1 --- 1.00000
a
 1.74958
b
 1.04876
a
 1.04799
a
 0.15558  0.003061  
12902043 LOC100298746 similar to protein phosphatase 2, regulatory subuni 1.00000
a
 1.17319
b
 1.00527
a
 1.02182
a
 0.04358  0.001923  
12882371 OR7E24 similar to Olfactory receptor 18 (Olfactory receptor 145- 1.00000
a
 1.42674
b
 1.01118
a
 1.06376
a
 0.08860  0.001017  
12854700 FBXL13 F-box and leucine-rich repeat protein 13 1.00000
a
 1.16934
b
 -1.03845
a
 1.03846
a
 0.05034  0.003826  
12717977 GHRH growth hormone releasing hormone 1.00000
a
 1.22927
b
 1.06399
a
 -1.00427
a
 0.06520  0.009874  
12712598 PDX1 pancreatic and duodenal homeobox 1  1.00000
a
 1.16694
b
 -1.02570
a
 1.02967
a
 0.05157  0.006236  
12682969 LOC100296558 hypothetical protein LOC100296558  1.00000
a
 1.41912
b
 1.15929
a
 1.08157
a
 0.07247  0.000266  
12674910 ---Intron --- 1.00000
a
 1.35052
b
 -1.21602
a
 1.12980
a
 0.11494  0.001786  
12729575 HBE1 hemoglobin, epsilon 1 1.00000
a
 1.07921
a,b
 -1.14303
b
 -1.10060
a,b
 0.06238  0.008809  
Cluster 7         
12856863 LDHB lactate dehydrogenase B 1.00000
a
 -1.02584
a
 -1.13592
a
 1.21088
b
 0.08583  0.007247  
12707574 VAMP5 vesicle-associated membrane protein 5 (myobrevin) 1.00000
a
 1.09221
a,b
 1.01750
a,b
 1.18502
b
 0.04999  0.008498  
12906833 LOC100337148 nuclear RNA export factor 3-like 1.00000
a
 1.20167
b
 1.03651
a,b
 1.34291
b
 0.08945  0.008903  
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Table 1. (Continued) 
12675356 ---Intron --- 1.00000
a
 1.10150
a
 -1.43145
b
 1.14442
a
 0.10746  0.000423  
12844091 TNFAIP8L2 tumor necrosis factor, alpha-induced protein 8-like 2 1.00000
a
 1.02130
a
 -1.10577
b
 1.07832
a
 0.04659  0.007207  
12770586 CDRT4 CMT1A duplicated region transcript 4 1.00000
a
 -1.04470
a,b
 -1.15988
b
 1.06567
a,b
 0.06043  0.009912  
12676756 ---Intron --- 1.00000
a
 1.13462
a,b
 -1.12408
a
 1.22693
b
 0.09456  0.009437  
12885754 LRRTM2 leucine rich repeat transmembrane neuronal 2 1.00000
a
 1.17937
b
 -1.03318
a
 1.12832
b
 0.05972  0.005353  
12675362 ---Intron --- 1.00000
a
 -1.15313
a,b
 -1.42605
c
 -1.24480
b,c
 0.09101  0.004356  
12678012 ---Intron --- 1.00000
a
 -1.00494
a
 -1.26902
b
 -1.10875
a
 0.06429  0.002107  
12857735 PLCZ1 phospholipase C, zeta 1  1.00000
a
 -1.06351
a,b
 -1.19444
c
 -1.13876
b,c
 0.04580  0.002755  
12910700 MCART6 similar to mitochondrial carrier triple repeat 6 1.00000
a
 1.05026
a
 -1.17399
b
 1.01611
a
 0.06033  0.006992  
12871908 FRAS1 similar to rCG64566  1.00000
a
 1.03201
a
 -1.17755
b
 -1.00326
a
 0.05950  0.009642  
12895450 SLC35D2 solute carrier family 35, member D2 1.00000
a
 -1.09449
b
 -1.13431
b
 1.00502
a
 0.04307  0.008158  
12732657 OR2AT4 similar to olfactory receptor Olr35 1.00000
a
 -1.03373
a,b
 -1.11814
b
 1.06801
a
 0.04643  0.007303  
12759892 LOC785933 similar to Orphan sodium- and chloride-dependent 
neurotra 
1.00000
a
 1.01002
a,b
 -1.14507
a
 1.15762
b
 0.06967  0.004500  
12914365 LOC100462699 --- 1.00000
a,b
 1.23788
b
 -1.26864
a
 1.13590
b
 0.11736  0.004271  
Cluster 8         
12915559 BOLA-DQA2 Bos taurus major histocompatibility complex, class II 1.00000
a
 -1.30149
a
 -1.21918
a
 2.66633
b
 0.37359  0.008451  
12870473 NPY1R neuropeptide Y receptor Y1 1.00000
a
 -1.31851
b
 -1.11101
a
 1.06292
a
 0.07942  0.001029  
12851703 TMEM168 transmembrane protein 168  1.00000
a,b
 -1.04902
b
 1.07443
a
 1.07428
a
 0.03587  0.005384  
12677980 ---Intron --- 1.00000
a
 -1.26612
b
 -1.11131
a,b
 1.20419
a
 0.10765  0.004477  
12805856 LOC521580 similar to histone cluster 1, H2bd  1.00000
a
 1.03429
a
 1.04456
a
 1.65795
b
 0.15039  0.004848  
12913565 ---PLOD1 --- 1.00000
a,b
 -1.16906
a
 -1.07681
a
 1.22793
b
 0.10040  0.008681  
12899187 LOC100297846 similar to trace amine associated receptor 8 1.00000
a
 -1.03889
a
 1.06342
a
 1.20792
b
 0.05900  0.002913  
12730199 LOC782645 similar to olfactory receptor Olr245 1.00000
a
 1.02972
a
 1.12569
a,b
 1.25095
b
 0.05992  0.003096  
12810320 ZNF236 zinc finger protein 236  1.00000
a,b
 -1.06458
a
 -1.03225
a
 1.05678
b
 0.03261  0.007426  
12878036 THG1L tRNA-histidine guanylyltransferase 1-like (S. cerevisiae) 1.00000
a
 -1.14203
b
 -1.07103
a,b
 -1.00782
a
 0.03735  0.003804  
12708470 LOC782479 similar to ribosomal protein L26 1.00000
a
 -1.21664
b
 -1.06766
a,b
 1.11736
a
 0.08608  0.009312  
12870694 SRP72 signal recognition particle 72kDa 1.00000
a,b
 -1.02321
a
 -1.08373
a
 1.08183
b
 0.04071  0.006627  
12857895 PUS7L pseudouridylate synthase 7 homolog (S. cerevisiae) 1.00000
a
 -1.10623
a
 -1.09610
a
 1.13670
b
 0.05312  0.000423  
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Table 1. (Continued) 
1
Se supplement treatments that contained no Se (Control) or 3 mg Se/day in the form of sodium selenite (ISe), 1.5 mg Se/day of each 
sodium selenite and SelPlex
®
 mix (Mix), or 3 mg Se/day of SelPlex
®
 (OSe) were top-dressed onto enough of a common cottonseed 
hull/soybean hull/cracked corn-based diet (0.08 mg Se per day) to support 0.5 kg/day growth in maturing Angus-cross heifers for 168 
days.  The abundance of gene transcripts are reported relative to the mean expression of the Control group and are expressed as the fold-
change of non-transformed data.  
2
Means with different superscripted letters differ (P < 0.05).  
3
A missing symbol indicates a lack of confirmed bovine DNA or RNA sequence annotation. 
4
The presented SEM values were pooled (averaged) from that of control (n = 9), ISe (n = 9), Mix (n = 9), and OSe (n = 9) treatment 
groups.  
5
P-values were obtained from one-way ANOVA F-test 
12743540 GOLGA3 golgi autoantigen, golgin subfamily a, 3 1.00000
a
 -1.06641
a,b
 -1.08873
b
 1.08322
a
 0.03868  0.000934  
12842784 FCGR2 Fc fragment of IgG, low affinity IIb, receptor (CD32)  1.00000
a
 -1.13416
a,b
 -1.27149
b
 1.13919
a
 0.08708  0.001204  
12747334 THOC5 THO complex 5  1.00000
a
 -1.08233
b
 -1.03511
a,b
 1.03841
a
 0.03025  0.004399  
12809240 ADNP2 ADNP homeobox 2 1.00000
a
 -1.10483
b
 -1.01514
a
 1.06486
a
 0.03198  0.000331  
12844243 SNAPIN SNAP-associated protein 1.00000
a
 -1.14259
b
 -1.19432
b
 -1.07056
a,b
 0.05038  0.007386  
12828917 ZNF22 zinc finger protein 22 (KOX 15)  1.00000
a
 -1.14634
b
 -1.18867
b
 -1.07987
a,b
 0.04388  0.002467  
12690686 ACIN1 apoptotic chromatin condensation inducer 1 1.00000
a
 -1.07579
b
 -1.11190
b
 -1.01875
a,b
 0.02836  0.002180  
12913489 ACLA_046210 DnaJ domain protein 1.00000
a
 -1.18778
a,b
 -1.40734
b
 1.12130
a
 0.11243  0.002185  
12840769 LEPRE1 leucine proline-enriched proteoglycan (leprecan) 1 1.00000
a
 -1.08090
a,b
 -1.11548
b
 1.05989
a
 0.04569  0.003257  
12677698 ---Intron --- 1.00000
a
 -1.12940
a
 -1.06740
a
 1.15727
b
 0.06441  0.001365  
12912371 GCLC glutamate-cysteine ligase, catalytic subunit 1.00000
a
 -1.24385
b
 -1.19484
b
 -1.23431
b
 0.06410  0.005740  
12913085 CEP350 centromere-associated protein 350 1.00000
a
 -1.56052
b
 -1.38906
b
 -1.08920
a
 0.10649  0.000839  
12708824 MIR2300B microRNA mir-2300b 1.00000
a
 -1.24583
b
 -1.32703
b
 -1.03539
a
 0.07937  0.001808  
6
6
 
67 
 
Table 2. Hepatic miRNA (Mir), and their putative mRNA targets, that were 
differentially expressed in response to dietary Se supplement.
1
 
MiR Molecules in Network
2
 Top Functions
3
 
Mir-222   
 ADCYAP1,DDHD1 Cell Morphology, Cell-To-Cell Signaling 
and Interaction, Cellular Assembly and 
Organization 
Mir-2393   
 
 
 
ABCF3,ACIN1,AKR1C3,CASP2,CBX1,CBX3,CCNA1,CCND1,CDKN2
A,CLDN2,CTNNB1,DIABLO,GCM1,GOLGA3,GSK3B,HDAC1,HIC1,H
NF1A,HNF4A,HTRA2,LRRTM2,MFI2,NFYC,PPARA,QPCT,RBM39,RI
N2,RUFY3,SAP18,SENP1,SRPK2,SRR,TANK,TSNAX,ZNF236 
Cell Cycle, Cancer, Neurological Disease 
 ADA,ADCYAP1,anandamide,Ca
2+
,CCL22,chemokine,CIB1,CXCL2,CXC
R2,D-
sphingosine,DDHD1,ENTPD1,Eotaxin,FCGR2A,FKBP4,HOMER1,Integr
in alpha 4 beta 1,ITGA2,ITPR3,LAMA1,leukotriene B4,Lfa-
1,MOG,Plcbeta,PTAFR,Rap1,SELPLG,SFTPD,SLC9A3R1,TRP,TRPC3,
TRPC4,TRPC5,VIPR1,Vla-4 
Cell Signaling, Molecular Transport, 
Vitamin and Mineral Metabolism 
 CRK,PCDHA2 Embryonic Development, Organ 
Development, Organismal Development 
 E2F1,ZNF22 Cancer, Cardiac Dysfunction, Cell Cycle 
 DLG4,FRAS1,GRIP1,GRIP2 Developmental Disorder, Genetic Disorder, 
Ophthalmic Disease 
 ADNP2,CBX1,CBX3,NFYC DNA Replication, Recombination, and 
Repair, Gene Expression, Cellular 
Assembly and Organization 
Mir-2300b   
 BCAR3,CCND1,CDK4,CSNK1A1,CSNK1D,CSNK1E,CTNNB1,DDR1,d
ihydrotestosterone,DYNC1I1,EBAG9,HADHB,HIST2H2BE,KAT7,KPN
A4,LRRTM2,MAPK14,NDC80,NGFR,NPY,PCM1,PKM2,RALY,RANB
P1,RCC1,RGS7,RUFY3,SNAPIN,TP53,TRPV1,Tubulin,UNC119,VRK1,
XPO1,ZFP106 
Cell Cycle, Cellular Assembly and 
Organization, DNA Replication, 
Recombination, and Repair 
 
 ELMOD1,THG1L Tissue Morphology, Cellular Growth and 
Proliferation, Cell Death 
 DLG4,FRAS1,GRIP1,GRIP2 Developmental Disorder, Genetic Disorder, 
Ophthalmic Disease 
 CTNNB1,dihydrotestosterone,SECISBP2,SEPW1 Organismal Injury and Abnormalities, Renal 
Damage, Renal and Urological Disease 
 
1
Differences in expression and dietary Se treatments are described in Table 1. 
2
The mRNA for these proteins were differentially expressed by the liver in response 
to supplemental Se treatment. 
3
The top biofuctions are identified for the differentially expressed genes in the left.  
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A 
 
B 
Figure 1. The correlation heat maps of 38 *. Cel files (A) before and 36 *.cel files (B) 
after removing two outliers. The heat maps were generated based on the correlation 
matrix (data are not shown). As indicated by the legend color box, gray color in the 
middle represents the correlation coefficient value, 0.90, red color on the rightmost 
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represents the highest correlation, and the blue color on the leftmost represents the 
lowest correlation. The intensity of the color reflects the relative intensity of 
correlation among chips. 8a indicates two chips are not correlated very well compared 
to other chips. Their individual average correlation coefficients are 0.84 and 0.94. 
After removing these two chips, 8b indicates the rest chips are correlated very well. 
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Figure 2. Principle component analysis of microarray transcriptome analysis of day 
168 liver samples at day 168 from Control (A/red), ISe (B/blue), Mix (C/green), and 
OSe (D/purple) maturing Angus-cross heifers.  The colored dots represent linear 
combinations of the relative expression data, including expression values and 
variances, of the 26,303 gene transcripts in each Bovine GeneChip. The center dot 
(centroid) for each treatment groups represents the overall treatment expression 
pattern.  
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Figure 3. Zen diagram depiction of the relationship of 139 differentially expressed 
gene transcripts by liver tissue of maturing Angus-cross heifers after 168 days of no 
supplemental Se (Control) or 3 mg Se/day in the form of sodium selenite (ISe), 1.5 
mg Se/day of each sodium selenite and SelPlex
®
 mix (Mix), or 3 mg Se/day of 
SelPlex
®
 (OSe).  Note that expression of eight transcripts differed among ISe, Mix, or 
OSe treatments, but not versus Control heifers. 
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32  
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22 
Mix 
33 
11 
22 4 
7 
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Figure 4. Hierarchical cluster analysis of 139 differentially expressed (P < 0.01) gene 
transcripts by liver tissue of maturing Angus-cross heifers after 168 days of no 
supplemental Se (Trt A, red) or 3 mg Se/day sodium selenite (Trt B, blue), 1.5 mg 
Se/day of each sodium selenite and SelPlex
®
 mix (Trt C, green), or 3 mg Se/day in the 
Cluster 6 
Cluster 7 
Cluster 8 
Cluster 4 
Cluster 5 
Cluster 1 
Cluster 2 
Cluster 3 
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form of SelPlex
®
 (Trt D, purple), as indicated by the top color bar. The expression 
level for each gene transcript was standardized to mean of 0 and scale to standard 
deviation of 1, which is the default setting of the Partek Genomics Suite software.  As 
indicated by the bottom color bar, gray color in the middle represents the mean value, 
0, red color represents gene expression levels above the mean expression whereas 
blue color denotes expression below the mean.  The intensity of the color reflects the 
relative intensity level of transcript expression. 
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Fig. 5. Liver selenium (Se) concentrations (lsmeans with SEM as error bars) in 
maturing beef heifers fed diets (224 days) supplemented with either no Se (Control) 
or 3 mg Se/day in the form of sodium selenite (ISe), sodium selenite/SelPlex
®
 mix 
(Mix) or SelPlex
®
 (OSe). Treatment, days on treatment, and treatment x days on 
treatment interaction effects (P ≤ 0.0001). Taken from Brennan et al.(2011).  
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Figure 6. The pathway of different forms of Se metabolism. The whole figure shows the details of the pathway through which Se 
obtained as dietary SeMet, SeCys, Selenate, and Selenite. After absorption and transport to the liver, they all are transformed to the 
selenide intermediate that is incorporated into selenoproteins or excreted through methylation (Suzuki, 2005). The routs they come to 
Selenide are different. Inorganic Se as Selenate and selenite must be reduced, either directly through the action of thioredoxin reductase 
plus thioredoxin, or react with GSH to form GS-Se-SG, then form GS-SeH by the GSH reductase, then forms selenide. (Lu J et al., 2009). 
In mammals, the selenate first be converted to selenite than participate the incorporation of selenoproteins. The conversion is catalyzed 
by the bifunctional enzyme (fusion product of two catalytic activities) involved two steps: sulfate adenylyltransferase catalyzes the 
formation of adenosine 5'-phosphosulfate (APS) from ATP and inorganic sulfate, then the APS is catalyzed by the adenylylsulfate kinase 
portion of 3'-phosphoadenosine 5'-phosphosulfate (PAPS) synthase to synthesize the selenite (Bandurski et al., 1956; Hilz and Lipmann, 
1955; Venkatachalam et al., 1998). The selenite can also be converted back to selenic acid, the latter will be adenylylated to 
adenylylselenate then phosphoralated to phosphoadenylylselenate catalyzed by the bifunctional enzyme phosphoadenosine-
phosphosulfate synthase (Lehninger, 2005; Salway, 2004). SeCys was through one step to be converted to selenide by the SeCys beta-
lyase, with the production of Alanine (Ohta and Suzuki, 2008). Besides, the methyltransferases can transfer one-carbon groups to SeCys 
to become methylSeCys, the later will be converted to gama-glutamyl-Se-methyl-SeCys, methyl-seleno-pyruvate, or methylselenol 
(Kegg. 2011). SeMet uses two paths to go into the Selenide. The primary one is by transselenation to convert into SeCys like the Met 
transfers to Cys (Suzuki, 2005), the intermediate Se-SAM was synthesized (Gammelgaard et al., 2011), this process is shown in the top. 
7
6
The other one is by a gama-lyase catalyzed reaction to produce methylselenol, then by a demethylation process to produce selenide 
(Suzuki, 2005). SeMet is also incorporated nonspecifically in place of Met into proteins, which is shown on the right top (review paper). 
Once selenide is prepared, it is either used for synthesis of selenoproteins (on the left top of Figure) or as an intermediate metabolite for 
Se excretion (on the bottom of Figure 6). Further steps in the assimilation of selenide into selenoproteins involve generation of 
selenophosphate through the activity of selenophosphate synthetase (Tamura et al., 2004) and then incorporation of Selenophosphate into 
selenocysteyl-tRNA
[Ser][Sec] 
(Allmang et al., 2009). Se is excreted through the intermediate Selenide. At adequate level of intake it is 
incorporated into selenosugar A and B for excretion in urine through the activity of methyltransferase and SAM (Kobayashi, et al., 2002). 
At higher levels of intake the methyltransferase add the methyl group from SAM to convert selenide to methylselenol then 
dimethylselenide, then trimethylselonium, which is excreted in the urine (Ohta and Suzuki, 2008, Krittaphol, 2010). The methylselenol 
can be reduced to methyl-selenic acid through a reversible reaction with the thioredoxin reductase (Moore et al., 1964; Speranza et al., 
1973; Arner and Holmgren, 2000)
7
7
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